WO2010142060A1 - Lhrh antagonist with long potency and low histamine releasing effect - Google Patents

Lhrh antagonist with long potency and low histamine releasing effect Download PDF

Info

Publication number
WO2010142060A1
WO2010142060A1 PCT/CN2009/000648 CN2009000648W WO2010142060A1 WO 2010142060 A1 WO2010142060 A1 WO 2010142060A1 CN 2009000648 W CN2009000648 W CN 2009000648W WO 2010142060 A1 WO2010142060 A1 WO 2010142060A1
Authority
WO
WIPO (PCT)
Prior art keywords
phe
ser
cpa
pro
mop
Prior art date
Application number
PCT/CN2009/000648
Other languages
French (fr)
Chinese (zh)
Inventor
刘克良
周宁
高永清
荣嫡
付慧君
林凡程
张文录
周文霞
张永祥
程军平
Original Assignee
中国人民解放军军事医学科学院毒物药物研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国人民解放军军事医学科学院毒物药物研究所 filed Critical 中国人民解放军军事医学科学院毒物药物研究所
Priority to PCT/CN2009/000648 priority Critical patent/WO2010142060A1/en
Publication of WO2010142060A1 publication Critical patent/WO2010142060A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides

Definitions

  • the present invention relates to a ten-derivative having an action of inhibiting the secretory glandular hormone and inhibiting the action of the secretory gland-secreting hormone, and a composition thereof, and a method for treating the prostate, the endometrium, and the reproductive Sex hormones are used in contraceptive diseases, contraception, and the like.
  • L Human-producing hormone
  • L is a hormone secreted by the inferior colliculus. Its main function is to promote the synthesis of sputum (L) and follicle stimulating hormone (F). Adolescence has a relationship with reproduction, birth and sex hormones. L consists of ten amino acids and contains . L is shown below
  • Pupeyy Leu rg oy H 2 L antagonizes L action and inhibits the release of L, so it can be used for the treatment of sex hormones such as prostate.
  • L antagonism has a fast speed, an overshoot phenomenon, and a serum hormone level. It can be expected that L antagonism before the treatment of the line, more patient acceptance, has greater prospects than punishment.
  • Ten derivatives or rest or physiological toxicity can be used for the treatment of prostate, uterine membrane, contraception and other sex hormone-dependent diseases. This aspect relates to a compound thereof (a ten derivative or resting or physiological toxicity,
  • , , and and may or may not contain, substituted or unsubstituted, straight or substituted or unsubstituted, straight or or substituted, or Unsubstituted, straight or oxy, substituted or unsubstituted, straight or substituted or unsubstituted, straight or substituted or unsubstituted, straight or oxy or oxy, substituted or unsubstituted, straight Or alternatively, substituted or unsubstituted, straight or or, or
  • Phosphoric acid which may be attached to p or any of the carbon atoms of , , , , and
  • n and p can be placed separately, for example 1, , , , ,
  • the atom of the unsubstituted gene or the genomic, nitro, or substituted sheep substituted or substituted or substituted or sheep or aromatic phenyl or the like may be unsubstituted or A gene, or a sheep or an aromatic gene, substituted or substituted by a substituted sheep, containing an atom, and or
  • medium 1 ( 1 a gene that is unsubstituted or substituted by a gene, or a substituted or substituted or substituted sheep, or a sheep or an aromatic gene, such as a phenyl or an unsubstituted or standing Substituted or substituted by a halogen nitro group, or a substituted sheep, containing an atom, or a sheep or aroma, , , etc.
  • Aa can be Phe or D P
  • Aa , aa and aa each may be L or type he )Phe( ) Phe( ph( c op phe> ph p ph g o p n n Ly y n o n t or any of ph
  • Aa, aa or aa can stand side by side with the following ( ) or (1)
  • n the integer of the place, for example, 1, , , or
  • the atomic genes of the atom are unsubstituted or substituted from halogen, nitro, or substituted sheep substituted or substituted or substituted, or sheep or forest aromatic gene phenyl or the like
  • An unsubstituted or substituted lysine, a nitro group, or a substituted or substituted, equimolar or aromatic atom, or a sheep or aromatic gene such as,
  • Aa may be Leu, c or c in this (1) derivative or rest or physiological toxicity, c
  • the method includes the following steps: the quaternary amino acid raw material is / B or B / E
  • the anti-complete/dioxane Bo 1 E neutralizing and lowering amino acid starting materials are obtained in this order, in which the ten amino acids are sequentially obtained by the final F cracking (F benzoyl g L. L pyrolysis temperature C is cleaved).
  • the average content of the cracking is completed, water, water (19 L), and chemistry.
  • Scheme 1 shown in Figure 1 represents the methods of this (1) ten derivative. This aspect refers to the method by which B and B are attached to (1) derivatives or rest or physiological toxicity.
  • This aspect relates to a derivative or compound containing at least (1) ten.
  • This mediation relates to the use of this (1) derivative or rest or physiological toxicity in the prevention or treatment of sex hormones (sex hormones, prostate, mucous membrane, mammary gland) or contraception.
  • This mediation relates to the present (1) derivatives or rest or physiological toxicity in each of the antagonistic, antagonistic L-suppression, inhibition of the secretory glandular hormone (and / or F) and / or inhibition of the gonadotropin-suppressing hormone (oral estrogen , the use of hormones and / or).
  • the present invention relates to the use of the present (1) derivatives or rest or physiological toxicity in each of reduced, reversed, etc.
  • This aspect relates to a method for preventing or treating a sex hormone related disease (sex hormones, prostate, uterine membrane, breast) or contraception, and the method includes administering an effective amount to a patient or a contraceptive (1 derivative or rest or Physiological toxicity.
  • the present invention relates to a method for antagonizing, antagonizing L-happiness, inhibiting secretory glandular hormones (such as and/or F), and/or inhibiting gonadotropin-suppressing hormones (oral estrogen, hormones and/or), and administering an effective amount to a subject in need thereof.
  • secretory glandular hormones such as and/or F
  • gonadotropin-suppressing hormones oral estrogen, hormones and/or
  • This aspect relates to methods for reducing release, reversal, etc., including administering an effective amount of (1) ten derivatives or rest or physiological toxicity.
  • This aspect refers to ( ) ( ) and the compound or derivative shown, Boc he( , Boc he( ) Boc he( ) Boc he( t ) Boc he( ) Boc p u e do he
  • the mediation relates to ( ), (1 1) and each of the compounds or derivatives shown, for example Boc h ( ) Boc he( ) Boc he( ) Boc he( 8u ) Boc he( ) Boc pue do he EL Boc Ly (F oc) L oc n(F oc) , L Boc Ly (Bz , F oc) Boc p(F oc) t Or each of the derivatives.
  • Alkyl carbon refers to the text of this article.
  • the oxycarbons include oxycarbyl and oxycarbon. Unless otherwise specified, "" refers to a substitution of a meso or alkene atom having about 1 about a carbon atom in a straight or a straight. The more normal one with 1 carbon atom has 1 carbon atom.
  • a "low” that is a component of a gene or a low oxy group, a low, a low sulphur, or a low component refers to a straight one or one carbon atom unless otherwise.
  • Sexuality includes , , , , , ,
  • Substituted by a medium or a substituted atom. May be 1, or, or from a halogen, nitro, amino, , or oxy group or
  • Sexuality includes ethylene, propylene, , ,
  • “" means carbon-carbon, which has about or about a carbon atom. It has 1 carbon atom and more has a carbon atom (for example, a carbon atom).
  • Sexuality includes , , , , , ,
  • Base and . It may be substituted by 1, or , or a nitro, amino, , or oxy group or a substitution.
  • the oxy group includes an oxy group, an oxy group, an oxy group, an oxy group, an oxy group, an oxy group, an oxy group and an oxy group.
  • includes , , , and , , or .
  • Sex includes benzene, 1 base and .
  • “" is a component of a gene or gene that is represented by a component of a carbon or a substituted carbon or a portion of a carbon or a cup, a partially saturated saturated carbon cup portion substituted with a phenyl group or ( ), in which a group and a group are combined, For example, oxygen, or hydrogen. Unless otherwise, the substitution may be substituted by ( or , , , ) which may be the same or different, wherein "aryl substituted” includes, for example, amino, oxy, oxycarbodioxy, sulfite, , , , amino, , oxy, oxy carbon,
  • aryl aryl, hydroxy, amino, oxy, nitro, nitro, nitro, oxy, oxy, Sulfin, oxycarbon, amino, amino, amino or
  • Alkoxy groups include oxy groups and 1 oxy or oxy groups. "” means that, among them. Sex is.
  • Alkyl means G group 0, of which is above.
  • the oxygen group includes an oxy group and an oxy group, which are each substituted.
  • Sexual sheep cups include , , , , , and .
  • the natural sheep include the uniform sheep.
  • Ben Youming's most capricious aromatic nai cup base includes ⁇ -2-yl, ⁇ --3-yl, 2- 4- or 5-imicy, 3- 4- or _ ⁇ ⁇ ⁇ , 2 -or 3-didentate and 1- or 2-carbo.
  • saturated or partially saturated or 6-symbolized cup bases of this friend include 1, 3, 5, 6, 2, 2, 2, 3, 4, _ or 1, 2 , 3,5,4- ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ 1, 1, 1, 2, 3,4,5- or 1,2,3,5,4-di-carbyl, 2-mimi-m, pyridine, sulphate, 1,2, 3- or 1,2 , 4-made three wow, morphine, um dimercapto, 1,2,4- 1,2,6-, 1, 3,2-, 1, 3,6- or 1,4,2- ⁇ ⁇ , ⁇ , ⁇ , 1,2-, 1, 3- or 1,4-pyranyl and 1,2,3-pyrrolidyl.
  • “Chai Cup Burning Base” means: (i) a cup-burning base of about 3-8 cups containing a medium or a multi-dye atom or a dye-containing atomic well from 0, S and NR R' Substituted by oxygen; (ii) partially saturated multi-cup containing a portion of the atomic carbon cup, wherein the aryl (or aryl) cup is replaced by an intervening or poly-"aryl substituent", The well and the cup-burning base are condensed together into a cup-shaped knot.
  • this gene include benzene dihydropyridyl, dioxanthene, dihydrogen and pyrrole [ , 2-a]
  • ⁇ , ⁇ () "The limb derivative and its stagnation and its metaphysical toxicity It does not have a good effect in hormone secretion, and it is a lower group in the measurement of rest, so it can be used as a hormone, especially for breastfeeding.
  • physiologically toxic refers to a compound which retains the expected physiological activity of the compound without any unanticipated side effects or compounds thereof.
  • the sub-containing can be , , , , , , etc.
  • the ten derivative or the composition of the resting or physiological toxicity or the composition containing the same may be administered orally, muscle, subcutaneously, etc. in any manner known, for example, chewing, , , , , , , . It can be general system, and various micro-organisms.
  • Yuxi such as water and various aqueous solutions, ethanol or other elements, Hugh, lactic acid, ethylene, , Wait.
  • the (1) derivative or resting or physiological toxicity depends on factors such as the nature and extent of the disease to be prevented or treated, the sex or age of the patient or the substance, the sensitivity, and the reversal of the compound used, We give, and we give effect to hope. It can be in the form of sheep or divided into two, three, and three forms. The sheep are not as big as g / g . 1 g / g rest , 1 g / g rest , better solid . 9/9 off. However, in some cases, it is also possible to use g/g or above or g/g for the following sheep.
  • Oxygen carbon oxygen carbon
  • Boc Ly (Bz) ( . 9, . o1) is dissolved in 10, a solution p 1 , L ox L ox dissolves F oc u ( . 9, . 1 1. ), slowly increases rest, sheep, keeps at room temperature anti. Go o, water to L extraction, p,
  • L. (Acetic acid water, 1 1). The upper step is dissolved in L water, the lower 1 a, p, L dioxane, L dioxygen dissolved F oc . ), Hugh. Reverse, normal temperature is reversed. L water, extraction
  • the solid phase synthesis of (.o1), the B/H, the amino acid sequence of the compound, and the Boc solid phase synthesis method (cf., synthesis, press, 1) operate to synthesize c a pa he e n op Leu g o a B .
  • Premature vaccination, glass capillary, serum by chemical light method for determination of serum content, content and rest and grouping only, subcutaneous injection or compound (different), 1, etc., p Q n will be obtained by using the sera ( eck an ou te public cce unoa ay y te)) Determination of serum content. 1
  • the ability to induce large abdominal mast cells is measured by male bloodletting, intraperitoneal injection of B L / only, abdominal cavity to the middle 1 p 1 ,
  • the sheep cells and cells are diluted with cells.
  • the upper cells have different C, and the boiling stops.
  • the upper B is converted to the percentage of intensity strength measured by E n E n ,

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides decapeptide derivatives with LHRH receptor antagonizing activity, pituitary gonadotrophin secretion inhibiting effect, and sex gland steroid hormone secretion inhibiting effect, the preparation process thereof, the pharmaceutical composition thereof, the use in the treatment of prostate cancer, endometrial cancer, and reproductive sex hormone dependence related disease, as well as the use in the contraception, etc.

Description

低 副作用的 L H拮抗 木領域  Low side effects of L H antagonism
本 涉及具有 L 休拮抗活性的、具有抑制 休分泌 性腺激素作用、 抑制性腺分泌 激素作用的十 衍生物 其制 各方法 它們的 物組合物及它們在治行*** 、 子宮內膜 、 生殖有夫的性激素依賴相夫疾病、 避孕等中的用途。 背景 木 The present invention relates to a ten-derivative having an action of inhibiting the secretory glandular hormone and inhibiting the action of the secretory gland-secreting hormone, and a composition thereof, and a method for treating the prostate, the endometrium, and the reproductive Sex hormones are used in contraceptive diseases, contraception, and the like. Background
L ( 休生成 釋放激素)是由下丘 分泌的 激素 , 它的主要作用是促迸 休合成 休生成 (L )和卵泡 刺激素(F ) *** 有和 生殖、 生有及性激素相夫 。 L 由十 氨基酸 組成, 含有 。 L 的 下所示 L (Hume-producing hormone) is a hormone secreted by the inferior colliculus. Its main function is to promote the synthesis of sputum (L) and follicle stimulating hormone (F). Adolescence has a relationship with reproduction, birth and sex hormones. L consists of ten amino acids and contains . L is shown below
p u p e y y Leu rg o y H2 L 拮抗 L 作用 而抑制 L 的釋放, 因此可 以用于性激素相夫疾病 *** 等 的治行。 相比, L 拮抗刑具有 速度快、 上沖現象、 、 血 清 激素水平可 等 。 可以預料, L 拮抗 治行前 的行 化于 , 更 患者 接受, 比 刑具有更大 的 前景。 Pupeyy Leu rg oy H 2 L antagonizes L action and inhibits the release of L, so it can be used for the treatment of sex hormones such as prostate. In contrast, L antagonism has a fast speed, an overshoot phenomenon, and a serum hormone level. It can be expected that L antagonism before the treatment of the line, more patient acceptance, has greater prospects than punishment.
目前所 的 L 拮抗 然已有很 ,但作力  At present, the L antagonism is already very good, but the effort
, 大 數仍然存在生物利用度低, 休 半衰期 , 釋放 高等不足之 , 限制了 L 拮抗刊在 床上的 。 另外, 它 矣 相似, L 拮抗 也很 口服 收。 我們 所 , 目前上市的 L 拮抗 都是非口服 往 。 因此, 本 的目的就是通 L 改造,增 或非 境的 定性 未 休內作用周期及增 生物活性, 提高 拮抗 的生物利用度 降低其組 副作用, 而得到未 低 甚至可口服的新型 L 拮抗 。 容 Large numbers still have low bioavailability, half-life, and high release, which limits L antagonism to be published in the bed. In addition, it is similar, and L antagonism is also very oral. Our company, the currently listed L antagonists are non-oral. therefore, The purpose of this study is to transform L, to increase or not the qualitative internal cycle and biological activity, to improve the bioavailability of antagonism and reduce the side effects of the group, and to obtain a new L antagonism that is not low or even oral. Capacity
本 明 研究現已 十 衍生物 The present study has now ten derivatives
a pa aa e aa a aa aa o a  a pa aa e aa a aa aa o a
或 休 休或 生理毒性 , 不 具有良好的 L 拮抗活性、 較長的休 作用 同以及較低的組 釋放副作用, 部 分化合物甚至 具有口服活性。因此 (1)十 衍生物或 休 休或 生理毒性 可作力 物用于*** 、 子宮 膜 、 避孕以及其它性激素依賴相夫疾病治行的用途。 本 方面涉及化合物 其 (1 十 衍生物或 休 休或 生理毒性 ,Or rest or physiological toxicity, does not have good L antagonistic activity, longer resting effect, and lower group release side effects, some compounds even have oral activity. Therefore, (1) Ten derivatives or rest or physiological toxicity can be used for the treatment of prostate, uterine membrane, contraception and other sex hormone-dependent diseases. This aspect relates to a compound thereof (a ten derivative or resting or physiological toxicity,
pa aa e aa a aa aa P o a  Pa aa e aa a aa aa P o a
其中, among them,
可 、 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 或 ( )  Yes , ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) or ( )
、 ,、 和 相互 立地可分別 , 含有或不含有 、 磷酸 、 等的取代或未取代的 , 直 或 , 取代或未取代的 , , 直 或 或者 , 取代或 未取代的 ,直 或 氧基,取代或未取代的 , 直 或 , 取代或未取代的 , 直 或 , 取代或 未取代的 , , 直 或 氧基或者 氧基, 取代或未取 代的 , , 直 或 或者 , 取代或未取代的 , , 直 或 或者 , 或 , , and , and may or may not contain, substituted or unsubstituted, straight or substituted or unsubstituted, straight or or substituted, or Unsubstituted, straight or oxy, substituted or unsubstituted, straight or substituted or unsubstituted, straight or substituted or unsubstituted, straight or oxy or oxy, substituted or unsubstituted, straight Or alternatively, substituted or unsubstituted, straight or or, or
( ,) , ( ,) ( ) , ( ) (例  ( ,) , ( ,) ( ) , ( ) (example
或 ( ,) , , , ( ,) ( , Or ( , ) , , , ( ,) ( ,
"  "
或 ( ,) ) 或  Or ( ,) ) or
、 磷酸 、 可以是 介或 p 立地連接在 、 ,、 ,和 的任何 介碳原子上  Phosphoric acid, which may be attached to p or any of the carbon atoms of , , , , and
、 n和 p可分別 立地 的 , 例如 1, , , ,  , n and p can be placed separately, for example 1, , , ,
其中, , 中 1 ( 1 ) 立地 自 、 和 等的 原子的 基因 未取代 的或 立地 素, 硝基, 或 的取代 羊取代 或 取代或 取代的 或 羊 或 芳香 苯 基或者 等 可 未取代的或 立地 自 素 硝基, 或 的取代 羊取代或 取代的、含有 1 立地 自 、 和 等的 原子的 、 、 或 羊 或 芳香基因, , 等  Wherein, , in the 1 (1) position, and the atom of the unsubstituted gene or the genomic, nitro, or substituted sheep substituted or substituted or substituted or sheep or aromatic phenyl or the like may be unsubstituted or A gene, or a sheep or an aromatic gene, substituted or substituted by a substituted sheep, containing an atom, and or
可 , ( ) ) v)或(v)  Yes, ( ) ) v) or (v)
Figure imgf000004_0001
Figure imgf000005_0001
Figure imgf000004_0001
Figure imgf000005_0001
其中, among them,
立地 的 , 例 , 1, , , , 或 ,,、 ,和 , 相互 立地可分別 、 取代或未取代的 Sites, examples, 1, , , , or , , , , , , , , , , , , , , , , , , , ,
"  "
, 直 或 , 取代或未取代的 , ,直 或 或 者 , 取代或未取代的 , 直 或 氧基, 取代或未取 代的 ,直 或 ,取代或未取代的 ,直 或  , straight or , substituted or unsubstituted, straight or or, substituted or unsubstituted, straight or oxy, substituted or unsubstituted, straight or substituted or unsubstituted, straight or
或 ( ,) , ( ,) ( ,) ( ,) (例 , , 或 ( ,) ,  Or ( , ) , ( , ) ( , ) ( ,) (example, , or ( ,) ,
( ) , ( ) , 或 ( ) ) q 立地 的 , 例如 1, , , 或  ( ) , ( ) , or ( ) ) q on the ground , for example 1, , , or
B可 ,或 ,  B can, or ,
,相互 立地可分別 、 取代或未取代的 ,直 或 , 取代或未取代的 , , 直 或 或者  Reciprocal, substituted or unsubstituted, straight or substituted, unsubstituted, straight or
取代或未取代的 , 直 或 氧基, 取代或未取代的 0 直 或 取代或未取代的 , 直 或  Substituted or unsubstituted, straight or oxy, substituted or unsubstituted, straight or substituted or unsubstituted, straight or
或 ( , ( ,) , ( , , ( ,) 例 , , 或 ( ,) , , , ( ,) , Or ( , ( , ) , ( , , ( , ) , , , or ( , ) , , , ( ,) ,
( ,) 或 ( ( , ) or (
" ,) ), 或 , q 立地 的整數, 例 , 1, , , , 或  " , ) ), or , q the integer of the place, for example, 1, , , , or
其中, 化 , 中 1 ( 1 ) 立地 自 、 和 等的 原子的 基因 未取代 的或 立地 自 素, 硝基, 或 的取代 羊取代 或 取代或 取代的 、 、 或 羊 或 芳香基因, 如苯 基或者 等 可 未取代的或 立地 自鹵素 硝基, 或 的取代 羊取代或 取代的、含有 1 立地 自 、 和 等的 原子的 、 或 羊 或 芳香 , , , 等Where, chemistry, medium 1 ( 1 a gene that is unsubstituted or substituted by a gene, or a substituted or substituted or substituted sheep, or a sheep or an aromatic gene, such as a phenyl or an unsubstituted or standing Substituted or substituted by a halogen nitro group, or a substituted sheep, containing an atom, or a sheep or aroma, , , etc.
aa 可 Phe或 D P Aa can be Phe or D P
aa , aa 和 aa 各 立地可 L或 型的 he )Phe( ) Phe( ph( c op phe> ph p ph g o p n n Ly y n o n t 或者 ph中的任何  Aa , aa and aa each may be L or type he )Phe( ) Phe( ph( c op phe> ph p ph g o p n n Ly y n o n t or any of ph
或者 or
aa, aa 或 aa 可相互 立地可力以下 ( )或 (1 ) 的  Aa, aa or aa can stand side by side with the following ( ) or (1)
Figure imgf000006_0001
Figure imgf000006_0001
其中, among them,
( ) - ( ) > ( ) ( P( > P( ) )P( ) ) " ( ) - ( ) > ( ) ( P( > P( ) )P( ) ) "
( ( ) ( ) 或 ( ( ) ( ) or
- ( ) ( ) - ( ) ( )
( ) ( ) 或  ( ) ( ) or
可 立地 的整數, 例如 , 1, , , , 或 相 0) " " 互 立地可分別 ( ) 、An integer that can be placed, for example, 1, , , , or Phase 0) "" can stand separately ( ),
( ) , 其中 和 , 分別 , 取代或未取代的 直 或 , 取代或未取代的 , , 直 或 或者 , 取代或未取代的 直 或 氧基, 取代或未取代的G , 直 或 或 ( ,) ,  ( ), wherein, and, respectively, substituted or unsubstituted straight or substituted or unsubstituted, straight or substituted, unsubstituted or unsubstituted straight or oxy, substituted or unsubstituted G, straight or or (,) ,
( ,) , ( ,) , ( ,) 例 , 或  ( , ) , ( , ) , ( , ) , , or
( ) , ( , 1 ( ) 或 ( ) , ( , 1 ( ) or
( ,) ), 或 , n 立地 的整數, 例 , 1, , , 或  ( ,) ), or , n the integer of the place, for example, 1, , , or
其中, , 中 1 ( 1 ) 立地 自 、 和 等的 原子的 基因 未取代 的或 立地 自鹵素, 硝基, 或 的取代 羊取代 或 取代或 取代的 、 、 或 羊 或 林芳香基因 苯 基或者 等 可 未取代的或 立地 素, 硝基, 或 的取代 羊取代或 取代的、含有 1 立地 自 和 等的 原子的 、 、 或 羊 或 芳香基因 如 , , 等 Wherein, , in the 1 (1) site, and the atomic genes of the atom are unsubstituted or substituted from halogen, nitro, or substituted sheep substituted or substituted or substituted, or sheep or forest aromatic gene phenyl or the like An unsubstituted or substituted lysine, a nitro group, or a substituted or substituted, equimolar or aromatic atom, or a sheep or aromatic gene such as,
aa 可 Leu, c 或 c 在本 (1)十 衍生物或 休 休或 生理毒性 中, 的是, c  Aa may be Leu, c or c in this (1) derivative or rest or physiological toxicity, c
Enan h 、Lau 、 P y 、 Buty y 、 o noy 、 gony 、 n > P pe dy o pho ny 、 或 t. Enan h , Lau , P y , Buty y , o noy , gony , n > P pe dy o pho ny , or t.
在本 (1)十 衍生物或 休 休或 生理毒性 , 的是, B ,。  In this (1) ten derivative or resting or physiological toxicity, is B,.
在本 (1)十 衍生物或 休 休或 生理毒性 中, 的是, aa he( ) Phe( ) Phe( ) ph( c) op phe ph p P o Uph g n u p h ( ) Ph ( ). In this (1) ten derivative or rest or physiological toxicity Among them, aa he( ) Phe( ) Phe( ) ph( c) op phe ph p P o Uph gnuph ( ) Ph ( ).
在本 (1)十 衍生物或 休 休或 生理毒性 L中, 化 的是, a a he( ) he( ) he( ) ph( c) o p op he ph ph D g n D n u p Phe In the (1) derivatives or rest or physiological toxicity L, a a he( ) he( ) he( ) ph( c) o p op he ph ph D g n D n u p Phe
he( ) ph(Lau y ) p (Pa y ) ph uty y ) , ph co noy ) D p ( e a gony ) ph( Et) ph( n ) ph( pe dy ) ph( o pho n ) ph( )或 ph( Et) 在本 (1)十 衍生物或 休 休或 生理 , 中 的是, a g Ly n n或 n  He( ) ph(Lau y ) p (Pa y ) ph uty y ) , ph co noy ) D p ( ea gony ) ph( Et ) ph( n ) ph( pe dy ) ph( o pho n ) ph( ) Or ph( Et) in this (1) ten derivative or rest or physiology, is ag Ly nn or n
在本 (1)十 衍生物或 休 休或 生理毒性 中, 的是 aa Leu, c 或 c 。 本 的 介方面涉及 各本 (1)十 衍生物的方法。 ( )d 衍生物的 各 固相合成方法 方法以 B  In the (1) derivatives or rest or physiological toxicity, aa Leu, c or c. This section refers to the method of each (1) ten derivative. Solid phase synthesis method for ( )d derivatives
休, oc 策略, 到 未。 Hugh, oc strategy, to no.
(1)十 衍生物的 各方法 1 中方案 1所示。  (1) Ten derivatives of each method 1 shown in Scheme 1.
方法包括以下步驟 將 十位的保 的氨基酸原料以 / B 或 B / E 合 B  The method includes the following steps: the quaternary amino acid raw material is / B or B / E
反 完全 /二氧 Bo 1 E 中 和 下 介氨基酸原料 按此順序依次將十 氨基酸都 到 上 將最終所得到的 F裂解( F 苯甲 g L . L 裂解溫度 C 裂解 同 )得到 , 其中平均 含量 裂解完成 , 水 , 水 ( 19 L) , , 化。 The anti-complete/dioxane Bo 1 E neutralizing and lowering amino acid starting materials are obtained in this order, in which the ten amino acids are sequentially obtained by the final F cracking (F benzoyl g L. L pyrolysis temperature C is cleaved). The average content of the cracking is completed, water, water (19 L), and chemistry.
化可以用中 化 ( 化 F a h 反相 1 otage公 休 2 / . 醋酸 水), 化 得到 大于 的 。 1所示方案 1表示本 ( 1 ) 十 衍生物的 各方法。 本 的 介方面涉及特 和B 接到上 (1)十 衍生物 或 休 休或 生理毒性 上的方法。  It can be neutralized (chemical F a h reversed 1 otage public 2 / . acetic acid water), and the larger is obtained. Scheme 1 shown in Figure 1 represents the methods of this (1) ten derivative. This aspect refers to the method by which B and B are attached to (1) derivatives or rest or physiological toxicity.
本 的 介方面涉及含至少 上 (1)十 衍生物或 合物。 本 的 介方面涉及本 (1)十 衍生物或 休 休或 生理毒性 在 各 于預防或治行性激素相夫疾病 ( 性激素相夫癌症, *** 、 子宮 膜 、 乳腺 )或避孕 的 物中的用途。  This aspect relates to a derivative or compound containing at least (1) ten. This mediation relates to the use of this (1) derivative or rest or physiological toxicity in the prevention or treatment of sex hormones (sex hormones, prostate, mucous membrane, mammary gland) or contraception.
本 的 介方面涉及本 (1)十 衍生物或 休 休或 生理毒性 在 各 于拮抗 、 拮抗 L 休、 抑制 休分泌 性腺激素( 和/或F )和/或抑制性腺分泌 矣激素( 口***、 激素和/或 )的 物中的用途。  This mediation relates to the present (1) derivatives or rest or physiological toxicity in each of the antagonistic, antagonistic L-suppression, inhibition of the secretory glandular hormone (and / or F) and / or inhibition of the gonadotropin-suppressing hormone (oral estrogen , the use of hormones and / or).
本 的 介方面涉及本 (1)十 衍生物或 休 休或 生理毒性 在 各 于降低 、 、 反 等的 物中的用途。 本 的 介方面涉及預防或治行性激素相夫疾病 ( 性激 素相夫癌症, *** 、 子宮 膜 、 乳腺 )或避孕的方法, 方法包括給予患者或避孕者有效 量的 (1 十 衍生物或 休 休或 生理毒性 。 The present invention relates to the use of the present (1) derivatives or rest or physiological toxicity in each of reduced, reversed, etc. This aspect relates to a method for preventing or treating a sex hormone related disease (sex hormones, prostate, uterine membrane, breast) or contraception, and the method includes administering an effective amount to a patient or a contraceptive (1 derivative or rest or Physiological toxicity.
本 的 介方面涉及拮抗 、 拮抗 L 休、 抑制 休分泌 性腺激素(例 和/或F )和/或抑制性腺分泌 矣激 素( 口***、 激素和/或 )的方法, 方法 給予需要 者有效 量的 (1)十 衍生物或 休 休或 生理毒性 。  The present invention relates to a method for antagonizing, antagonizing L-happiness, inhibiting secretory glandular hormones (such as and/or F), and/or inhibiting gonadotropin-suppressing hormones (oral estrogen, hormones and/or), and administering an effective amount to a subject in need thereof. (1) Ten derivatives or rest or physiological toxicity.
本 的 介方面涉及降低 釋放、 、 反 等 的方法, 方法包括給予需要者有效 量的 (1)十 衍生物或 休 休或 生理毒性 。 本 的 介方面涉及 ( ) ( )及 所示化合物或 衍 生物, Boc he( 、 Boc he( ) Boc he( ) Boc he( t ) Boc he( ) Boc p u e do he This aspect relates to methods for reducing release, reversal, etc., including administering an effective amount of (1) ten derivatives or rest or physiological toxicity. This aspect refers to ( ) ( ) and the compound or derivative shown, Boc he( , Boc he( ) Boc he( ) Boc he( t ) Boc he( ) Boc p u e do he
E > L Boc Ly (F oc) L Boc n(F oc) L Boc Ly (Bz F oc) oc p(F oc) > 、 或 衍生物。  E > L Boc Ly (F oc) L Boc n (F oc) L Boc Ly (Bz F oc) oc p(F oc) > , or a derivative.
本 的 介方面涉及 ( )、 (1 1)及 所示化合物或 衍生 物 的 各 , 例 Boc h ( ) Boc he( ) Boc he( ) Boc he( 8u ) Boc he( ) Boc p u e do he EL Boc Ly (F oc) L oc n(F oc) 、 L Boc Ly (Bz ,F oc) Boc p(F oc) t 或 衍生物的 各。 The mediation relates to ( ), (1 1) and each of the compounds or derivatives shown, for example Boc h ( ) Boc he( ) Boc he( ) Boc he( 8u ) Boc he( ) Boc pue do he EL Boc Ly (F oc) L oc n(F oc) , L Boc Ly (Bz , F oc) Boc p(F oc) t Or each of the derivatives.
本 的 介方面涉及 ( ) )及 所示化合物或 衍 生物, Boc he( ) Boc he( ) Boc he( ) oc he( 、 Boc he( ) Boc p u e do he This aspect refers to ( ) ) and the compound or derivative shown, Boc he( ) Boc he( ) Boc he( ) oc he( , Boc he( ) Boc p u e do he
> E L Boc Ly (F oc) L oc n(F oc)  > E L Boc Ly (F oc) L oc n(F oc)
L oc Ly ( z ,F oc) oc p(F oc) u 、 或 衍生物等在降低 、 、 反 方面的用途。 本 所用木 " (1)十 衍生物 休 休"是指 相 的 或 L 休 。 本 的化 方案,本 (1)十 衍生物或 休 休或 生理毒性 自下面的十 或 休 休或 生理毒性的The use of L oc Ly ( z , F oc) oc p(F oc) u , or a derivative thereof in reducing, and inversely. The wood used in this article is "(1) Ten Derivatives Rest" means phase or L. The present scheme, this (1) derivative or rest or physiological toxicity from the following ten or rest or physiological toxicity
) c a pa a e g a Leu g a  ) c a pa a e g a Leu g a
( ) a pa he e g a Leu g o a  ( ) a pa he e g a Leu g o a
( ) aP pa Pa e g Pa Leu g o a  ( ) aP pa Pa e g Pa Leu g o a
( ) a pa he e n Pa Leu g o a  ( ) a pa he e n Pa Leu g o a
( ) a pa a e n a Leu g o a ( ) a pa a e n a Leu g o a
( ) c a pa he e n Pa Leu g o a -- -( ) ca pa he en Pa Leu goa -- -
(7)Ac D Na Gl-n D-Pa-6(7)Ac D Na Gl-n D-Pa-6
l Le-u' Ar-g P - 0 --rD-Cp-a D-Pa-l Se-r'  l Le-u' Ar-g P - 0 --rD-Cp-a D-Pa-l Se-r'
ro D-A-la1 N-H Ro D-A-la1 N-H
(8)NH CO D Nal1 D Cpa D Phe Ser Gln D Pal Leu Arg Pro D Ala10 (8) NH CO D Nal1 D Cpa D Phe Ser Gln D Pal Leu Arg Pro D Ala10
NH NH
(9)NH-CO-D--N-al1-D--C-pa-D--Pal--Ser--G-ln-D--Pal--Leu--Arg - -P-ro-D--Ala1-NH  (9) NH-CO-D--N-al1-D--C-pa-D--Pal--Ser--G-ln-D--Pal--Leu--Arg--P-ro- D--Ala1-NH
(10)D-Na1'-D-Cpa-D-P 9 he-Ser-Asn-D-Pa 6 (10) D-Na1'-D-Cpa-D-P 9 he-Ser-Asn-D-Pa 6
1-Leu-Arg-Pro-D-Alal-NH  1-Leu-Arg-Pro-D-Alal-NH
(11)D-Na-rD-Cp-a D-Pa-l Se-r' As-n D-Pa-l Le-u Ar-g Pr-o D A-la-l NH- (11) D-Na-rD-Cp-a D-Pa-l Se-r' As-n D-Pa-l Le-u Ar-g Pr-o D A-la-l NH-
(12)Ac D Na(12)Ac D Na
1-0 - r-D-Cpa-D-Phe-Ser-Asn-D-Pal-Leu-Arg- Pro-D-Ala-NH  1-0 - r-D-Cpa-D-Phe-Ser-Asn-D-Pal-Leu-Arg- Pro-D-Ala-NH
(13)Ac D NaT D Cpa D Pa1 Ser Asn D Pa 6 (13)Ac D NaT D Cpa D Pa1 Ser Asn D Pa 6
1 Leu Arg 9  1 Leu Arg 9
Pro D AlaI NHPro D AlaI NH
(14)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Asn--D-- 6 (14) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Asn--D-- 6
Pal--Leu--Ar g--Pro--D--Ala10--NH  Pal--Leu--Ar g--Pro--D--Ala10--NH
(15)N-H CO-D-Nal'-D-Cpa -D Pal-Ser--Asn -D Pal-Leu-Ar 9 (15) N-H CO-D-Nal'-D-Cpa -D Pal-Ser--Asn -D Pal-Leu-Ar 9
- g-Pro D A- g-Pro D A
?- la10 ?- la10
NH  NH
(16)D-Nal1-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Arg-Pro -D-Ala'-NH  (16) D-Nal1-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Arg-Pro-D-Ala'-NH
(17)D-Na-l1 D-Cp-a D-Pa-l Se-r Mp-h D-Pa-l Le-u Ar-g Pr-o D A-la-l NH- (17) D-Na-l1 D-Cp-a D-Pa-l Se-r Mp-h D-Pa-l Le-u Ar-g Pr-o D A-la-l NH-
(18)Ac D NarD Cpa D Phe Ser Mph D Pal Leu Arg 9 (18)Ac D NarD Cpa D Phe Ser Mph D Pal Leu Arg 9
Pro D Ala10Pro D Ala10
NH NH
(19)Ac-D-Nar-D-Cpa-D-Pal-Ser-Mph-D- 6 (19)Ac-D-Nar-D-Cpa-D-Pal-Ser-Mph-D- 6
Pal-Leu-Arg- Pro-D-Ala10-NH - -- -Pal-Leu-Arg- Pro-D-Ala10-NH - -- -
(20)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Ar g-Pro-D-Ala10-NH (20) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Ar g-Pro-D-Ala10-NH
(21)NH CO D NaT D Cpa D Pa1 Ser Mph D Pa1 Leu Ar g Pro D Ala10 (21) NH CO D NaT D Cpa D Pa1 Ser Mph D Pa1 Leu Ar g Pro D Ala10
NH  NH
s (22)Ac--D--Nal'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg8-- Pro--D--Ala10--NH s (22)Ac--D--Nal'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg8-- Pro--D-- Ala10--NH
(23)Ac-D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg- Pro-D-Ala10-NH  (23)Ac-D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg- Pro-D-Ala10-NH
(24)Ac-D Nal1 D Cpa D-Phe-Ser-Uph D Mo (24)Ac-D Nal1 D Cpa D-Phe-Ser-Uph D Mo
9 0 - -- - -p-Leu-Arg-0 Pro-D Al-a1-NH - 9 0 - -- - -p-Leu-Arg-0 Pro-D Al-a1-NH -
(25)Ac-D-Nal1-D-Cpa-D-Phe-Ser'-Phe(NAM)-D-Mop-Leu- Arg-Pro-D-Ala10-NH (25)Ac-D-Nal1-D-Cpa-D-Phe-Ser'-Phe(NAM)-D-Mop-Leu- Arg-Pro-D-Ala10-NH
(26)Ac D Nal1 D Cpa D Phe Ser Phe(NNM) D Mop Leu Arg8 Pro9 D AlaI0 (26)Ac D Nal1 D Cpa D Phe Ser Phe(NNM) D Mop Leu Arg8 Pro9 D AlaI0
NH NH
s (27)Ac--D--Nar--D--Cpa--D--Phe--Ser'--Phe(NOM)---D-Mop--Leu-- Arg--Pro---D-Ala-10-NH s (27)Ac--D--Nar--D--Cpa--D--Phe--Ser'--Phe(NOM)---D-Mop--Leu-- Arg--Pro-- -D-Ala-10-NH
(28)Ac D Nal' D Cpa-D-Phe-Ser-Aph(Ac) -D M-o 6 p -Leu -A - 9 -- -- rg Pro -D-Ala1 -NH  (28)Ac D Nal' D Cpa-D-Phe-Ser-Aph(Ac) -D M-o 6 p -Leu -A - 9 -- -- rg Pro -D-Ala1 -NH
(29)A-c D N-al-1 D C-pa-D P-he S-er A-ph-(DMe)- D M-op L-eu -Ar-g Pro-D Ala10 (29) A-c D N-al-1 D C-pa-D P-he S-er A-ph-(DMe)- D M-op L-eu -Ar-g Pro-D Ala10
NH  NH
(30)D-Nal1-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg-Pro -D-Alal-NH  (30) D-Nal1-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg-Pro-D-Alal-NH
(31)D NarD Cpa D Phe Ser Aph D Mop Leu A 9 rg Pro D A 1 (31)D NarD Cpa D Phe Ser Aph D Mop Leu A 9 rg Pro D A 1
U NH U NH
(32)D-Nar-D-Cpa-D-Phe-Ser-Uph-D-Mop-Leu-Arg-Pro -D-Alal-NH - -- -(32) D-Nar-D-Cpa-D-Phe-Ser-Uph-D-Mop-Leu-Arg-Pro -D-Alal-NH - -- -
(33)D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mo 6(33) D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mo 6
p-Leu-Arg -Pro-D-Ala1-NH  p-Leu-Arg -Pro-D-Ala1-NH
(34)D NarD Cpa D Phe Ser Phe(NOM) D Mo 6 (34)D NarD Cpa D Phe Ser Phe(NOM) D Mo 6
p Leu Arg Pro D Ala1 NH  p Leu Arg Pro D Ala1 NH
s (35)D--Nar--D--Cpa--D--Phe--Ser--Aph(Ac)--D-M-op--Leu--Arg --Pro--D--Ala10--NH s (35)D--Nar--D--Cpa--D--Phe--Ser--Aph(Ac)--DM-op--Leu--Arg --Pro--D--Ala10- -NH
(36)D Nar--D Cpa--D Phe--Ser -Aph(D-Me) -D-Mop-Leu-Arg -Pro -D-Ala10 (36)D Nar--D Cpa--D Phe--Ser -Aph(D-Me) -D-Mop-Leu-Arg -Pro -D-Ala10
-NH  -NH
(37)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Phe-D-Mop-Leu-Ar0 g-Pro-D-Ala10-NH  (37) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Phe-D-Mop-Leu-Ar0 g-Pro-D-Ala10-NH
(38)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Aph-D-Mop-Leu-Ar g-Pro-D-Ala10-NH  (38) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Aph-D-Mop-Leu-Ar g-Pro-D-Ala10-NH
(39)NH CO D Nal1 D Cpa D Phe Ser' Uph D Mo 6 (39) NH CO D Nal1 D Cpa D Phe Ser' Uph D Mo 6
p Leu Ar g Pro D Ala10 p Leu Ar g Pro D Ala10
NH NH
s (40)NH CO--D--Nal'--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Le u--Arg--P 9s (40)NH CO--D--Nal'--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Le u--Arg--P 9
ro--D--Ala10--NH  ro--D--Ala10--NH
(41)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D 6 (41) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D 6
-Mop-Le u-Arg-Pro-D-Ala1-NH  -Mop-Le u-Arg-Pro-D-Ala1-NH
(42)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-Le u-Arg-Pro--D Ala-1 NH  (42) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-Le u-Arg-Pro--D Ala-1 NH
(43)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac) -D M-o 6 (43) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac) -D M-o 6
p -Leu A-rg -Pro -D A-la10-NH  p -Leu A-rg -Pro -D A-la10-NH
(44)NH CO D NarD Cpa D Phe Ser Aph(DMe) D Mo 6 p Le u Arg Pro D Ala10 (44) NH CO D NarD Cpa D Phe Ser Aph (DMe) D Mo 6 p Le u Arg Pro D Ala10
NH NH
(45)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg -Pro-D-Ala10-NH - -- -(45) NTA-D-Nal'-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg-Pro-D-Ala10-NH - -- -
(46)NTA D NarD Cpa D Phe Ser Aph D Mop6(46) NTA D NarD Cpa D Phe Ser Aph D Mop6
Leu Arg Pro9 Leu Arg Pro9
D Ala10 D Ala10
NH  NH
(47)NTA (47)NTA
9 -D 9 -D
0 -Nal1 0 -Nal1
-D-Cpa-D-Phe 6 -D-Cpa-D-Phe 6
-Ser-Uph D Mo-p-Leu-Arg -Pro-D Al-a1-NH - (48)NTA--D--Nal'--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Leu- -Arg--Pro--D--Ala10 -Ser-Uph D Mo-p-Leu-Arg -Pro-D Al-a1-NH - (48)NTA--D--Nal'--D--Cpa--D--Phe--Ser-- Phe(NAM)--D--Mop--Leu--Arg--Pro--D--Ala10
--NH  --NH
(49)NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)--D Mop-Leu A - rg-Pro--D Ala-1 NH  (49) NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)--D Mop-Leu A - rg-Pro--D Ala-1 NH
(50)NTA-D-Nal' D Cpa 6 (50)NTA-D-Nal' D Cpa 6
D Phe Ser Phe(NOM) D Phe Ser Phe (NOM)
0 -- -- - - -D-Mop-Leu -Arg-Pro-D-Ala1-NH  0 -- -- - - -D-Mop-Leu -Arg-Pro-D-Ala1-NH
(51)NTA D NarD Cpa D Phe Ser Aph(Ac) D Mop Leu Arg Pro9 D Ala1 NH  (51) NTA D NarD Cpa D Phe Ser Aph(Ac) D Mop Leu Arg Pro9 D Ala1 NH
( 6 52)NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph(-DM-e) D-Mop-Leu -Arg-P-ro9 D-Ala!0 ( 6 52)NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph(-DM-e) D-Mop-Leu -Arg-P-ro9 D-Ala!0
NH NH
(53)NDN--D--Nal'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg- -Pro--D--Ala10--NH  (53)NDN--D--Nal'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg--Pro--D--Ala10 --NH
(54)NDN-D (54)NDN-D
0 -Nar-D-Cpa-D-Phe-Ser-Aph D Mo-p-Leu-Arg -Pro-D Al-a1 0 -Nar-D-Cpa-D-Phe-Ser-Aph D Mo-p-Leu-Arg -Pro-D Al-a1
-NH - -NH -
(55)NDN-D-Nar-D-Cpa-D-Phe-Ser-Uph D Mo-p6(55)NDN-D-Nar-D-Cpa-D-Phe-Ser-Uph D Mo-p6
-Leu-Arg -Pro-D Al-a10 -Leu-Arg -Pro-D Al-a10
-NH - -NH -
(56)NDN D NarD Cpa D Phe Ser Phe(NAM) D Mo 6(56)NDN D NarD Cpa D Phe Ser Phe(NAM) D Mo 6
p Leu Arg Pro D Ala1 NH  p Leu Arg Pro D Ala1 NH
(57)NDN D Nal' D Cpa D Phe Ser Phe(NNM) D Mop Leu Arg Pro D Ala10 (57)NDN D Nal' D Cpa D Phe Ser Phe(NNM) D Mop Leu Arg Pro D Ala10
NH NH
(58)NDN-D-Na1'-D-Cpa-D-Phe-Ser-Phe(NOM)-D-Mop-Leu -Arg- 9 (58)NDN-D-Na1'-D-Cpa-D-Phe-Ser-Phe(NOM)-D-Mop-Leu-Arg- 9
Pro-D-Ala10-NH - -- -Pro-D-Ala10-NH - -- -
(59)NDN-D-Nar-D-Cpa-D-Phe-Ser'-Aph(Ac) -op -Leu - o -D-A a10 -D M (59)NDN-D-Nar-D-Cpa-D-Phe-Ser'-Aph(Ac) -op -Leu - o -D-A a10 -D M
Arg -Pr l -NH Arg -Pr l -NH
(60)NDN D Na1' D Cpa' D Phe'Ser' Aph(DMe) D Mo 6 (60)NDN D Na1' D Cpa' D Phe'Ser' Aph(DMe) D Mo 6
p Leu Arg Pro D Ala10 p Leu Arg Pro D Ala10
NH NH
(61)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe--Leu--Arg-- Pro--D--Ala1--NH  (61)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe--Leu--Arg-- Pro--D--Ala1- -NH
(62)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg- Pro-D-Ala1-NH  (62)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg- Pro-D-Ala1-NH
(63)Ac-D-NalI-D-Cpa-D-Phe-Ser-Mop-D-Up 6 (63)Ac-D-NalI-D-Cpa-D-Phe-Ser-Mop-D-Up 6
h Leu-Arg-Pro-D Al-a10-NH - h Leu-Arg-Pro-D Al-a10-NH -
(64)Ac-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu- Arg-Pro-D-Ala1-NH (64)Ac-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu- Arg-Pro-D-Ala1-NH
(65)Ac D Nal1 D Cpa D Phe Ser Mop D Phe(NNM) Leu Arg Pro D Ala10 (65)Ac D Nal1 D Cpa D Phe Ser Mop D Phe(NNM) Leu Arg Pro D Ala10
NH NH
(66)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)-6-Leu-- Arg--Pro---D-AlaI-0-NH  (66)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)-6-Leu-- Arg--Pro--- D-AlaI-0-NH
(67)Ac-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(Ac) -Leu -A rg -Pro -D-Ala1 -NH  (67)Ac-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(Ac) -Leu -A rg -Pro -D-Ala1 -NH
(68)A-c D N-al-' D C-pa-D P-he S-er M-op-D A-ph(DM-e)6 (68) A-c D N-al-' D C-pa-D P-he S-er M-op-D A-ph(DM-e)6
L-euA -r-g Pro-9 L-euA -r-g Pro-9
D Ala10 D Ala10
NH  NH
(69)D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe6-Le 9 u-Arg-Pro -D-Alal-NH  (69) D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe6-Le 9 u-Arg-Pro -D-Alal-NH
(70)D Nal1 D Cpa D Phe Ser Mop D Aph Leu Arg Pro D AlaI0 (70)D Nal1 D Cpa D Phe Ser Mop D Aph Leu Arg Pro D AlaI0
NH NH
(71)D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph-Leu-Arg-Pro -D-Alal-NH - -- -(71) D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph-Leu-Arg-Pro-D-Alal-NH - -- -
(72)D Nal1 D Cpa D Phe Ser Mop D Phe(NAM) Leu Arg Pro D Ala10(72)D Nal1 D Cpa D Phe Ser Mop D Phe(NAM) Leu Arg Pro D Ala10
NH  NH
(73)D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6 (73) D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6
-Leu-Arg -Pro-D-Ala10 -Leu-Arg -Pro-D-Ala10
-NH -NH
(74)D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)--Leu--Arg --Pro--D--Ala10 (74) D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)--Leu--Arg --Pro--D--Ala10
--NH  --NH
(75)D Nar--D Cpa--D Phe--Ser M-op -D Aph-(A-c) L-eu A-rg P-ro D-A-la10 (75)D Nar--D Cpa--D Phe--Ser M-op -D Aph-(A-c) L-eu A-rg P-ro D-A-la10
N-H  N-H
(76)D Nar--D Cpa--D Phe--Ser -Mop -D Aph-(D-Me) -Leu-Arg -Pro -D-AlaI0 (76)D Nar--D Cpa--D Phe--Ser -Mop -D Aph-(D-Me) -Leu-Arg -Pro -D-AlaI0
-NH  -NH
(77)NH C0 D Na C 6 (77)NH C0 D Na C 6
pa D Phe r g Pro D Ala10 rD Ser' Mop D Phe Leu A Pa D Phe r g Pro D Ala10 rD Ser' Mop D Phe Leu A
NH  NH
(78)NH C0-D-Nar 6 (78) NH C0-D-Nar 6
-D-Cpa-D-Phe-Ser-Mop-D-Aph Leu-Ar g-Pro-D Al-a1 C - (79)NH O-NH --D -D-Cpa-D-Phe-Ser-Mop-D-Aph Leu-Ar g-Pro-D Al-a1 C - (79)NH O-NH --D
aI --Nal1 aI --Nal1
--D--Cpa--D--Phe--Ser'--Mop--D--Uph6-Leu--Ar g--Pro--D-Al- --D--Cpa--D--Phe--Ser'--Mop--D--Uph6-Leu--Ar g--Pro--D-Al-
(80)NH C--NH - 0-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Le u-Arg-Pro-D-Ala10(80) NH C--NH - 0-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Le u-Arg-Pro-D-Ala10
-NH  -NH
(81)NH CO-D-Nar-D Cpa D Phe Ser Mop D Phe(NNM) Leu A -- - - -- - - rg-Pro--D Ala1 (81) NH CO-D-Nar-D Cpa D Phe Ser Mop D Phe(NNM) Leu A -- - - -- - - rg-Pro--D Ala1
-NH-  -NH-
(82)NH C0 D Nal' D Cpa' D Phe'Ser' Mop' D Phe(N0M) Le u Arg Pro9(82)NH C0 D Nal' D Cpa' D Phe'Ser' Mop' D Phe(N0M) Le u Arg Pro9
D Ala1 NH  D Ala1 NH
(83)NH C0 D Na1' D Cpa D Phe Ser Mop D Aph(Ac)6 (83)NH C0 D Na1' D Cpa D Phe Ser Mop D Aph(Ac)6
Leu Arg Pro D Ala10 Leu Arg Pro D Ala10
NH NH
(84)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(DMe)6-Le u-Arg-Pro-D-Ala10-NH - -(84) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(DMe)6-Le u-Arg-Pro-D-Ala10-NH - -
(85- )NTA- D NarD Cpa D Phe Ser -Mop-D-Phe-Leu-Arg Pro9(85- )NTA- D NarD Cpa D Phe Ser -Mop-D-Phe-Leu-Arg Pro9
D Ala10 D Ala10
NH  NH
(86)NTA-D (86)NTA-D
0 -Na1'-D-Cpa-D-Phe-Ser' -Mop-D-Aph-Leu-Arg -Pro-D Al-a1 0 -Na1'-D-Cpa-D-Phe-Ser' -Mop-D-Aph-Leu-Arg -Pro-D Al-a1
- (87)NTA-NH - (87)NTA-NH
--D--Na1'--D--Cpa--D--Phe--Ser' -Mop-D-Uph-Leu-Arg8 - -Pro--D-Al-a10 --D--Na1'--D--Cpa--D--Phe--Ser' -Mop-D-Uph-Leu-Arg8 - -Pro--D-Al-a10
--NH  --NH
(88)NTA - -D-Na1'-D-Cpa-D-Phe-Ser' -Mop-D-Phe(NAM)-Leu -Arg-Pro-D-Ala1 (88)NTA - -D-Na1'-D-Cpa-D-Phe-Ser' -Mop-D-Phe(NAM)-Leu -Arg-Pro-D-Ala1
-NH  -NH
(89)NTA-D-Nar-D-Cpa-D-Phe-Ser' -Mop-D-Phe(NNM)-Leu A 0 (89)NTA-D-Nar-D-Cpa-D-Phe-Ser' -Mop-D-Phe(NNM)-Leu A 0
rg-Pro--D Ala1 rg-Pro--D Ala1
-NH  -NH
(90)NTA D NarD Cpa D Phe Ser' -Mop-D-Phe(NOM)-Leu Arg Pro D Ala1 NH  (90) NTA D NarD Cpa D Phe Ser' -Mop-D-Phe(NOM)-Leu Arg Pro D Ala1 NH
(91)NTA-D-Nar-D-Cpa-D-Phe-Ser -Mop-D-Aph(Ac)-Leu- - Arg -Pr-o D A-la10 (91)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)-Leu- - Arg -Pr-o D A-la10
NH NH
(92)NTA -Mop-D-Aph(DMe)-Leu - 9 (92) NTA -Mop-D-Aph(DMe)-Leu - 9
-Arg--P-ro-D--D-Arg--P-ro-D--D
---Nar--D--Cpa--D--Phe--Ser ---Nar--D--Cpa--D--Phe--Ser
-Ala10-NH  -Ala10-NH
(93)NDN-D-Nar-D-Cpa-D-Phe-Ser - 。 (93) NDN-D-Nar-D-Cpa-D-Phe-Ser - .
Mop一D一Phe-Leu'-Arg -Pro-D-Ala10 Mop-D-Phe-Leu'-Arg-Pro-D-Ala10
-NH  -NH
(94)NDN-D-Nal! (94)NDN-D-Nal!
-D-Cpa-D-Phe-Ser' -Mop-D-Aph-Leu-Arg -Pro-D Al-a1 -D-Cpa-D-Phe-Ser' -Mop-D-Aph-Leu-Arg -Pro-D Al-a1
-NH - -NH -
(95)NDN D NarD Cpa D Phe Ser -Mop-D-Uph-rLe_(95)NDN D NarD Cpa D Phe Ser -Mop-D-Uph-rLe_
u.'-Al _ rg Pro D Ala10 u.'-Al _ rg Pro D Ala10
NH  NH
(96)NDN D Nal' D Cpa D Phe Ser -Mop-D-Phe(NAM)-Leu Arg Pro9 D Ala10 (96)NDN D Nal' D Cpa D Phe Ser -Mop-D-Phe(NAM)-Leu Arg Pro9 D Ala10
NH NH
(97)NDN-D-Nal!-D-Cpa-D-Phe-Ser -Mop-D-Phe(NNM)-Leu -Arg-Pro-D-Ala10-NH - - -- -(97)NDN-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Leu-Arg-Pro-D-Ala10-NH - - -- -
(98)NDN D Na Mop(98)NDN D Na Mop
9 -- r-D-Cpa-D-Phe-Ser- -D-Phe(NOM)-Leu- Arg-Pro--D Ala-10 9 -- r-D-Cpa-D-Phe-Ser- -D-Phe(NOM)-Leu- Arg-Pro--D Ala-10
NH  NH
(99)NDN D Nal' D Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala10 (99)NDN D Nal' D Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala10
NH NH
(100)ND-N--D-Nal-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph-(DMe)--Le - u-Ar-g--Pro--D-Ala10-NH  (100) ND-N--D-Nal-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph-(DMe)--Le - u- Ar-g--Pro--D-Ala10-NH
(101)Ac-D-Nar-D-Cpa-D-Phe-Ser-Leu-D-Mop-Leu-Arg- 9 (101)Ac-D-Nar-D-Cpa-D-Phe-Ser-Leu-D-Mop-Leu-Arg- 9
Pro-D-Ala10-NH  Pro-D-Ala10-NH
(102)Ac-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mop-Leu-Arg -Pro-D-Ala10-NH  (102)Ac-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mop-Leu-Arg-Pro-D-Ala10-NH
(103)Ac-D-Nal'-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-Arg -Pro-D-Ala1-NH  (103)Ac-D-Nal'-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-Arg-Pro-D-Ala1-NH
(104)Ac D Nal1 D Cpa D Phe Ser Glu D Mop Leu Arg Pro9 D Ala10 (104)Ac D Nal1 D Cpa D Phe Ser Glu D Mop Leu Arg Pro9 D Ala10
NH NH
(105)Ac--D--Nal1--D--Cpa--D--Phe--Ser'--Gln--D--Mop--Leu--Arg - -Pro--D--Ala10--NH  (105)Ac--D--Nal1--D--Cpa--D--Phe--Ser'--Gln--D--Mop--Leu--Arg--Pro--D--Ala10 --NH
(106)A-c D N-al-! D C-pa-D P-he S-er' A-rg-D M-op L-eu A-rg P-ro-D A-la10 (106) A-c D N-al-! D C-pa-D P-he S-er' A-rg-D M-op L-eu A-rg P-ro-D A-la10
NH  NH
(107)D-Na1!-D-Cpa-D-Phe-Ser-Leu-D-Mop-Leu-A 8 rg-Pro-D-Ala10-NH  (107) D-Na1!-D-Cpa-D-Phe-Ser-Leu-D-Mop-Leu-A 8 rg-Pro-D-Ala10-NH
(108)D-Nar-D-Cpa D Phe-Ser-Tyr-D-Mop-Leu-Arg-Pr o-D-Ala10 -- -NH  (108) D-Nar-D-Cpa D Phe-Ser-Tyr-D-Mop-Leu-Arg-Pr o-D-Ala10 ---NH
(109)D NarD Cpa D Phe Ser Lys D Mop Leu Arg Pr o D Ala10 (109)D NarD Cpa D Phe Ser Lys D Mop Leu Arg Pr o D Ala10
NH NH
(110)D-Na1'-D-Cpa'-D-Phe'-Ser'-GIu-D-Mop6-Leu-Arg-Pr o-D-Ala10-NH -- -(110)D-Na1'-D-Cpa'-D-Phe'-Ser'-GIu-D-Mop6-Leu-Arg-Pr oD-Ala10-NH -- -
(111)D Nal1 6(111)D Nal1 6
-D-Cpa-D-Phe-Ser'-Gln-D-Mop-Leu-Arg-Pr o-D-Ala1 - -NH  -D-Cpa-D-Phe-Ser'-Gln-D-Mop-Leu-Arg-Pr o-D-Ala1 - -NH
(112)D Nal1 D Cpa D Phe Ser Arg D Mop Leu Arg Pr o D Ala10 (112)D Nal1 D Cpa D Phe Ser Arg D Mop Leu Arg Pr o D Ala10
NH NH
(113)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Leu--D--Mop6 (113)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Leu--D--Mop6
--Leu--A rg--Pro--D--Ala10--NH  --Leu--A rg--Pro--D--Ala10--NH
(114)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mo 6 (114) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mo 6
p-Leu-A rg-Pro-D-Ala10-NH  p-Leu-A rg-Pro-D-Ala10-NH
(115)NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-A rg- 9 (115) NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-A rg- 9
Pro-D-Ala10-NH  Pro-D-Ala10-NH
(116)NH CO-D-Nar-D-Cpa-D-Phe-Ser-GIu-D-Mop-Leu-A rg-P 9 (116) NH CO-D-Nar-D-Cpa-D-Phe-Ser-GIu-D-Mop-Leu-A rg-P 9
ro-D-Ala1-NH  ro-D-Ala1-NH
(117)NH CO D NarD Cpa D Phe Ser Gln D Mop Leu A rg Pro D Ala10 (117) NH CO D NarD Cpa D Phe Ser Gln D Mop Leu A rg Pro D Ala10
NH NH
(118)N-H CO--D--Nal1--D--Cpa--D-Phe--Ser-Arg--D--Mop-6-Leu--A rg--Pro-9--D-Ala-1-NH  (118) NH CO--D--Nal1--D--Cpa--D-Phe--Ser-Arg--D--Mop-6-Leu--A rg--Pro-9--D- Ala-1-NH
(119)D N-a1-' D C-pa-' D P-he-' Ser-' Phe-(NNM) D Mo-p-Leu-Ar g -Pro -D Ala-10 (119)D N-a1-' D C-pa-' D P-he-' Ser-' Phe-(NNM) D Mo-p-Leu-Ar g -Pro -D Ala-10
-NH - -NH -
( 6 120)NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-Leu-' Arg-Pro--D Ala-10( 6 120)NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-Leu-' Arg-Pro--D Ala-10
NH  NH
(121)NTA-D-Nar-D-Cpa-D-Phe-Ser'-Phe(-CA-M) D Mop -Le u -Arg -Pro D--Ala10-NH  (121) NTA-D-Nar-D-Cpa-D-Phe-Ser'-Phe(-CA-M) D Mop -Le u -Arg -Pro D--Ala10-NH
(122)NTA D NarD Cpa D Phe Ser Mop D Phe(COOH) L eu Arg Pro D Ala10 (122) NTA D NarD Cpa D Phe Ser Mop D Phe(COOH) L eu Arg Pro D Ala10
NH NH
(123)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)6-Le u-Arg-Pro-D-Ala10-NH - - --(123)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)6-Le u-Arg-Pro-D-Ala10-NH - - --
(124)NDN D Nal1- D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-L eu-Arg-P 9-- - ro--D Ala-10(124)NDN D Nal1- D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-L eu-Arg-P 9-- - ro--D Ala-10
NH  NH
(125)NDN D NarD Cpa D Phe Ser' Phe(CAM) D Mop Le u Arg Pro D Ala1 NH (125)NDN D NarD Cpa D Phe Ser' Phe(CAM) D Mop Le u Arg Pro D Ala1 NH
(126)NDN--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Phe(COOH)6 (126)NDN--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Phe(COOH)6
--L eu--Arg--Pro---D-Ala-1-NH  --L eu--Arg--Pro---D-Ala-1-NH
( 6 127)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10-NH  ( 6 127)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10-NH
(128)CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg-Pro-D-Ala1-NH  (128) CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg-Pro-D-Ala1-NH
(129)CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Le u-Arg-Pro-D-Ala10-NH  (129) CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Le u-Arg-Pro-D-Ala10-NH
(130)CAM D Na1' D Cpa' D Phe' Ser' Mop' D Phe(NOM)6 (130)CAM D Na1' D Cpa' D Phe' Ser' Mop' D Phe(NOM)6
Le u Arg Pro D Ala1 NH Le u Arg Pro D Ala1 NH
(131)CAM--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Phe(CAM)--Le u'--Arg--Pro--D--Ala10--NH  (131)CAM--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Phe(CAM)--Le u'--Arg --Pro--D--Ala10--NH
(132)CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10 (132) CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10
NH  NH
(133)CEC D Na1' D Cpa (NAM) (133)CEC D Na1' D Cpa (NAM)
9 -- -- '-D-Phe'-Ser'-Mop'-D-Phe -Leu-Arg-Pro-D-Ala10-NH  9 -- -- '-D-Phe'-Ser'-Mop'-D-Phe -Leu-Arg-Pro-D-Ala10-NH
(134)CEC-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Le u-Arg-Pro-D-Ala1-NH  (134) CEC-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Le u-Arg-Pro-D-Ala1-NH
(135)CEC D NarD Cpa D Phe Ser Mop D Phe(NOM) Le u Arg Pro D Ala10 (135) CEC D NarD Cpa D Phe Ser Mop D Phe (NOM) Le u Arg Pro D Ala10
NH NH
(136)CEC-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10-NH - - -- -(136) CEC-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10-NH - - -- -
(137)CEC-D-Nal'-D-Cpa-D-Phe-Ser-Mop D Ph-e(C-OOH)-L eu-Arg-Pro--D Ala-1 NH (137) CEC-D-Nal'-D-Cpa-D-Phe-Ser-Mop D Ph-e(C-OOH)-L eu-Arg-Pro--D Ala-1 NH
(138)CAM D Na1' D Cpa D Phe Ser Phe(NAM) D Mo 6 p Le u Arg Pro D Ala10 (138)CAM D Na1' D Cpa D Phe Ser Phe(NAM) D Mo 6 p Le u Arg Pro D Ala10
NH  NH
s (139)CAM--D--Na1'--D--Cpa--D--Phe--Ser--Phe(NNM)--D--Mop--Le u--Arg--Pro--D--Ala1--NH s (139)CAM--D--Na1'--D--Cpa--D--Phe--Ser--Phe(NNM)--D--Mop--Le u--Arg--Pro- -D--Ala1--NH
(140)CAM (140) CAM
Pro9 -D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)-D-M 6 op-Le u-Arg- -D-Ala10-NH  Pro9 -D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)-D-M 6 op-Le u-Arg- -D-Ala10-NH
(141)CAM-D-Nal'-D-Cpa'-D-Phe'-Se 6 r'-Phe(CAM) -D M-op -Le0 u -Arg -Pro -D-Ala10-NH  (141) CAM-D-Nal'-D-Cpa'-D-Phe'-Se 6 r'-Phe(CAM) -D M-op -Le0 u -Arg -Pro -D-Ala10-NH
(142)CAM-D-Nal'-D-Cpa'-D-Phe'-Ser'-Phe(COOH)--D Mop-L eu-Arg-Pro--D Ala-10 (142) CAM-D-Nal'-D-Cpa'-D-Phe'-Ser'-Phe(COOH)--D Mop-L eu-Arg-Pro--D Ala-10
NH  NH
(143)CEC D Na1' D Cpa D Phe Ser Phe(NAM) D Mop Le u Arg8 (143)CEC D Na1' D Cpa D Phe Ser Phe(NAM) D Mop Le u Arg8
Pro9 D AlaI NH Pro9 D AlaI NH
(144)CEC--D--Nar--D--Cpa--D--Phe--Ser'--Phe(NNM)--D--Mop--Le u--Arg--Pro--D--Ala10--NH  (144) CEC--D--Nar--D--Cpa--D--Phe--Ser'--Phe(NNM)--D--Mop--Le u--Arg--Pro-- D--Ala10--NH
(145)CEC-D-Na1' D Cpa-D-Phe-Ser-Phe(NOM) 6 (145) CEC-D-Na1' D Cpa-D-Phe-Ser-Phe(NOM) 6
-D-Mop-Le u-Arg-Pro9-D-Ala10-- -NH  -D-Mop-Le u-Arg-Pro9-D-Ala10-- -NH
(146)CEC-D-Nar-D-Cpa-D-Phe-Ser (146) CEC-D-Nar-D-Cpa-D-Phe-Ser
10 -Phe(CAM) -D M-op -Le u -Arg -Pro -D-Ala -NH  10 -Phe(CAM) -D M-op -Le u -Arg -Pro -D-Ala -NH
(147)CEC D-N-al' D Cpa D Phe S-e 6 r P-he(C-OO-H) D-Mop eu-Arg-P- 0 -- -- -L ro D-Ala1 NH  (147) CEC D-N-al' D Cpa D Phe S-e 6 r P-he(C-OO-H) D-Mop eu-Arg-P- 0 -- -- -L ro D-Ala1 NH
(148)NH CO D Nal' D Cpa D Phe Ser Aph D Ap 6 h Leu A rg Pro D Ala10 (148) NH CO D Nal' D Cpa D Phe Ser Aph D Ap 6 h Leu A rg Pro D Ala10
NH NH
(149)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Aph-Leu-A rg-Pro9-D-Ala10-NH - -- -(149) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Aph-Leu-A rg-Pro9-D-Ala10-NH - -- -
(150)NH CO-D Na(150) NH CO-D Na
0 - r-D-Cpa-D-Phe-Ser'-Uph-D-Aph-Leu-A rg-Pro-D-Ala1-NH  0 - r-D-Cpa-D-Phe-Ser'-Uph-D-Aph-Leu-A rg-Pro-D-Ala1-NH
(151)NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph'-D-Uph'-Leu'-A rg Pro9 D Ala10 (151) NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph'-D-Uph'-Leu'-A rg Pro9 D Ala10
NH NH
(152)NH CO D NarD Cpa D Phe-Ser-Gln-D-Uph-Leu-A rg--Pro--D--Ala1-0 - -- -- --NH  (152) NH CO D NarD Cpa D Phe-Ser-Gln-D-Uph-Leu-A rg--Pro--D--Ala1-0 - -- -- --NH
(153)NH CO D Nar-D-Cpa-D-Phe-Ser-Uph D U-ph-Leu-A rg 9 -- -Pro-D A-la-10 (153) NH CO D Nar-D-Cpa-D-Phe-Ser-Uph D U-ph-Leu-A rg 9 -- -Pro-D A-la-10
NH- NH-
(154)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Uph Leu-Arg-Pro-D Al-a1-NH (154) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Uph Leu-Arg-Pro-D Al-a1-NH
(155)NH CO-D NaI1 - D Cpa-D-Phe-Ser-Aph(-Ac-) D Aph(-Ac )-Leu-Arg-P-9- -- ro D-Ala10 (155) NH CO-D NaI1 - D Cpa-D-Phe-Ser-Aph(-Ac-) D Aph(-Ac )-Leu-Arg-P-9- -- ro D-Ala10
NH  NH
(156)NH CO D Nal1 D Cpa D Phe Ser' Gln D Aph(Ac) Le u Arg Pro D Ala1 NH (156) NH CO D Nal1 D Cpa D Phe Ser' Gln D Aph(Ac) Le u Arg Pro D Ala1 NH
(157)NH CO--D--Nar--D--Cpa--D--Phe--Ser'--Uph--D--Aph(-Ac)--Le u--Arg--Pr-o9-D-A-la10-NH  (157) NH CO--D--Nar--D--Cpa--D--Phe--Ser'--Uph--D--Aph(-Ac)--Le u--Arg--Pr -o9-DA-la10-NH
(158)NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph Leu-C it-Pro-D A-la-1 NH- (158) NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph Leu-C it-Pro-D A-la-1 NH-
(159)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(-Ac) -Leu C-it P-ro9-D Al-a10(159) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(-Ac) -Leu C-it P-ro9-D Al-a10
NH  NH
(160)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-I Iys-Pro9 (160) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-I Iys-Pro9
-D-Ala10-NH  -D-Ala10-NH
(161)NH CO D NarD Cpa D Phe Ser Mop D Ap 6 (161) NH CO D NarD Cpa D Phe Ser Mop D Ap 6
h Leu I orn Pro D Ala10 h Leu I orn Pro D Ala10
NH NH
(162)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-A rg-Pro9-D-Ala10-NH (163)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Pro-D-Mop-Leu-A rg--Pro--D--Ala1--NH (162) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-A rg-Pro9-D-Ala10-NH (163) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Pro-D-Mop-Leu-A rg--Pro--D--Ala1--NH
(164)NH CO--D--Nal!--D--Cpa--D--Phe--Ser--Mop--D--Aph--Leu--G  (164) NH CO--D--Nal!--D--Cpa--D--Phe--Ser--Mop--D--Aph--Leu--G
In Pro D Ala1 NHIn Pro D Ala1 NH
(165)NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu L ys(Bzl)-Pro-D-Ala1-NH  (165) NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu L ys (Bzl)-Pro-D-Ala1-NH
(166)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph-Leu-A sp-Pro-D-Ala1-NH  (166) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph-Leu-A sp-Pro-D-Ala1-NH
(167)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Asn-Leu-A rg-Pro9-D-Ala10-NH  (167) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Asn-Leu-A rg-Pro9-D-Ala10-NH
(168)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Glu--Leu--A rg--Pro9--D--Ala10--NH  (168) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Glu--Leu--A rg--Pro9--D-- Ala10--NH
(169)NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu G Iu Pro D Ala10 (169)NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu G Iu Pro D Ala10
NH NH
(170)NH CO--D--Nal'--D--Cpa--D--Phe--Ser--Mop--D--Aph6-Leu--A sn--Pro--D-A-la-10-NH- (170) NH CO--D--Nal'--D--Cpa--D--Phe--Ser--Mop--D--Aph6-Leu--A sn--Pro--DA-la -10-NH-
(171)NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Amp(-Ac) -Le u A-rg -Pr-o9(171) NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Amp(-Ac) -Le u A-rg -Pr-o9
D A-laI0 D A-laI0
NH  NH
(172)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-A 6 (172) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-A 6
mp-Leu-A rg -Pro9 mp-Leu-A rg -Pro9
-D-Ala10 -D-Ala10
N-H  N-H
(173)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Mop Leu-I Lys-Pro-D Al-a1-NH - (173) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Mop Leu-I Lys-Pro-D Al-a1-NH -
(174)NH CO D NarD Cpa D Phe Ser Mop D Phe(CAM) L eu Ilys Pro D Ala10(174) NH CO D NarD Cpa D Phe Ser Mop D Phe (CAM) L eu Ilys Pro D Ala10
NH NH
(175)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Amp(Ac)-Le u-Glu-Pro-D-Ala10-NH - -- -(175) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Amp(Ac)-Le u-Glu-Pro-D-Ala10-NH - -- -
(176)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop D M 6(176) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop D M 6
-op-Leu-G Iu P-ro D-Ala-10-NH - -op-Leu-G Iu P-ro D-Ala-10-NH -
(177)NH CO D NarD Cpa D Phe Ser Aph(Ac) D Mop (A cc) A 9(177) NH CO D NarD Cpa D Phe Ser Aph(Ac) D Mop (A cc) A 9
rg Pro D Ala10 Rg Pro D Ala10
NH NH
(178)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Aph(-Ac-)-D-Mop--(A cc)'--Arg--Pro--D--Ala10--NH  (178) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Aph(-Ac-)-D-Mop--(A cc)'--Arg-- Pro--D--Ala10--NH
(179)NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(Ac)-(A cc)-Arg-Pro9-D-Ala10-NH  (179) NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(Ac)-(A cc)-Arg-Pro9-D-Ala10-NH
(180)NH C-O-D Na-r-D Cp-a-D Ph-e Se-r Mo-p-D Ap-h(Ac)- (Ac-c) -Ar-g Pro-D Ala10 (180) NH C-O-D Na-r-D Cp-a-D Ph-e Se-r Mo-p-D Ap-h(Ac)- (Ac-c) -Ar-g Pro-D Ala10
NH  NH
(181)NTA-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Pro6-Leu-Arg -Pro9-D-Ala10-NH  (181) NTA-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Pro6-Leu-Arg-Pro9-D-Ala10-NH
(182)NTA D NarD Cpa D Phe Ser Gln D Mop Leu Arg Pro D Ala10 (182) NTA D NarD Cpa D Phe Ser Gln D Mop Leu Arg Pro D Ala10
NH NH
(183)NTA--D--NalI--D--Cpa--D--Phe--Ser--Gln-D-A-ph-(Ac)--Leu -Ar-g-Pr-o-D--Al-a1-NH- (183) NTA--D--NalI--D--Cpa--D--Phe--Ser--Gln-DA-ph-(Ac)--Leu-Ar-g-Pr-oD--Al -a1-NH-
(184)NTA (184) NTA
c) Arg8 -D-Na1'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Mop-(Ac - -Pro9-D-Ala10-NH c) Arg8 -D-Na1'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Mop-(Ac - -Pro9-D-Ala10-NH
(185)NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph(-Ac-) D Mo 6 (185) NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph(-Ac-) D Mo 6
p cc) ro D A 0 p cc) ro D A 0
la1 -(A -Arg8-P -- -NH  La1 -(A -Arg8-P -- -NH
(186)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)-(Ac C)-Arg-Pro-D-Ala10-NH  (186) NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)-(Ac C)-Arg-Pro-D-Ala10-NH
(187)NTA D NarD Cpa D Phe Ser Mop D Aph(Ac) (Ac c) Arg Pro D Ala10 (187) NTA D NarD Cpa D Phe Ser Mop D Aph(Ac) (Ac c) Arg Pro D Ala10
NH NH
(188)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop- 6 (188) NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop- 6
D-Asn-Leu-Arg -Pro-D-Ala10-NH - -- -D-Asn-Leu-Arg -Pro-D-Ala10-NH - -- -
(189)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Glu-Leu-Arg -Pro-D-Ala1-NH (189) NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Glu-Leu-Arg-Pro-D-Ala1-NH
(190)NTA D Nal' D Cpa D Phe Ser Aph D Mop Leu Arg Pro9 (190) NTA D Nal' D Cpa D Phe Ser Aph D Mop Leu Arg Pro9
D Ala10 D Ala10
NH NH
(191)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(Enanth y1-)-Le-u-Ar-g-Pr-o--D-Al-a10-NH  (191) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(Enanth y1-)-Le-u-Ar-g-Pr -o--D-Al-a10-NH
(192)NH CO-D-Nar-D Cpa-D-Phe-Ser'-Mop-D-Aph(Lauryl )6 (192) NH CO-D-Nar-D Cpa-D-Phe-Ser'-Mop-D-Aph(Lauryl)6
L-eu A-rg P-ro9 L-eu A-rg P-ro9
D-A-la10- NH- D-A-la10- NH-
(193)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Palmityl)-Leu-Arg-Pro--D Ala-10(193) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Palmityl)-Leu-Arg-Pro--D Ala-10
NH  NH
(194)NH CO-D-Nal1-D-Cpa D Phe Ser Mop D Aph(Butyry 1) Le-u Ar-g Pr-9 (194) NH CO-D-Nal1-D-Cpa D Phe Ser Mop D Aph (Butyry 1) Le-u Ar-g Pr-9
o D-Al NH- o D-Al NH-
(195)NH CO D 1-a10 -- - - -- Nal D Cpa D Phe Ser Mop D Aph(Nicoti noyl) Leu Arg P 9(195) NH CO D 1-a10 -- - - -- Nal D Cpa D Phe Ser Mop D Aph (Nicoti noyl) Leu Arg P 9
ro D Ala10 Ro D Ala10
NH NH
(196)NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Aph(Pe-larg - onyl)--Leu--Arg---Pro-D--Ala10-NH  (196) NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Aph(Pe-larg-onyl)--Leu--Arg-- -Pro-D--Ala10-NH
(197)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Uph(Di-E-t) Le-u Ar-g Pr-o9 (197) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Uph(Di-E-t) Le-u Ar-g Pr-o9
D-Al-a10 D-Al-a10
NH- NH-
(198)NH CO-D-Nal1(198) NH CO-D-Nal1
-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di n Pr) -Leu-Arg-Pro9 -D-Cpa-D-Phe-Ser-Mop-D-Uph(Di n Pr) -Leu-Arg-Pro9
-D Al-a10 -D Al-a10
-NH - -NH -
(199)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Piperi dyl C-O) L-eu A-rg P-ro D-A-la10(199) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Piperi dyl C-O) L-eu A-rg P-ro D-A-la10
N-H  N-H
(200)NH CO D NarD Cpa D Phe Ser Mop D Aph(Morpho 1iny1 CO) Leu Arg Pro D Ala10 (200) NH CO D NarD Cpa D Phe Ser Mop D Aph (Morpho 1iny1 CO) Leu Arg Pro D Ala10
NH NH
(201)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-i-P r)-Leu-Arg-Pro-D-Ala10-NH (201) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-i-P r)-Leu-Arg-Pro-D-Ala10-NH
? - - - -- -? - - - -- -
(202)NH CO D N-ar-D Cpa-D P-he-Ser-Mop-D U-ph-(Di Et) -Leu-A - -- 0 - rg Pro D Ala1-NH (202) NH CO D N-ar-D Cpa-D P-he-Ser-Mop-D U-ph-(Di Et) -Leu-A - -- 0 - rg Pro D Ala1-NH
(203)Enanthyl D NarD Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala1 NH (203)Enanthyl D NarD Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala1 NH
(204)Lauryl-D--Nal1-D--C-pa-D--P-he-S -M-op-D--A-ph(Ac)- L-eu-A-rg- 9 (204) Lauryl-D--Nal1-D--C-pa-D--P-he-S-M-op-D--A-ph(Ac)- L-eu-A-rg- 9
P-ro-D--A-la1- -er P-ro-D--A-la1- -er
0-N-H  0-N-H
(205)Palmity-l-D Nar--D Cpa--D Phe-Ser-Mop--D Aph(Ac)-Leu-Arg-Pro-D-Ala1-NH  (205) Palmity-l-D Nar--D Cpa--D Phe-Ser-Mop--D Aph(Ac)-Leu-Arg-Pro-D-Ala1-NH
(206)Butyryl D-Na-l! D-Cp-a D-Ph-e Se-r Mo-p D-Ap-h(Ac)6 Le-u Ar-g Pr-o D-Al-a10 (206) Butyryl D-Na-l! D-Cp-a D-Ph-e Se-r Mo-p D-Ap-h(Ac)6 Le-u Ar-g Pr-o D-Al-a10
NH- NH-
(207)Nicotinoyl-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(A c)6-Leu-Arg-Pro-D-Ala10(207) Nicotinoyl-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(A c)6-Leu-Arg-Pro-D-Ala10
-NH  -NH
(208)Pelargonyl D Nal! D Cpa D Phe Ser Mop D Aph(A c) Leu Arg 9 (208) Pelargonyl D Nal! D Cpa D Phe Ser Mop D Aph(A c) Leu Arg 9
Pro D A 0 Pro D A 0
la1 NH La1 NH
(209)Di--E-t-N-CO-D--N-ar-D--C-pa-D--P-he-S-er-M-op-D--A-ph(Ac )- 9 (209)Di--E-t-N-CO-D--N-ar-D--C-pa-D--P-he-S-er-M-op-D--A-ph(Ac )- 9
L-eu-A-rg-P-ro-D--A-la10-N-H  L-eu-A-rg-P-ro-D--A-la10-N-H
(210)Di n Pr N-CO-D-Nar-D-Cpa -D-Phe -Ser M-op -D-Aph( Ac) -Leu -Arg -Pro -D-Ala10 (210) Di n Pr N-CO-D-Nar-D-Cpa -D-Phe -Ser M-op -D-Aph( Ac) -Leu -Arg -Pro -D-Ala10
-NH  -NH
(211)Piperidyl C-O D-N-al1 D-C-pa D-P-he S-er M-op D-A-ph (Ac) L-eu A-rg P-ro D-A-la10 (211) Piperidyl C-O D-N-al1 D-C-pa D-P-he S-er M-op D-A-ph (Ac) L-eu A-rg P-ro D-A-la10
N-H  N-H
(212)Mo-rp-hol-inyl-C-O D N-al-! D C-pa-D P-he S-er M-op-D A ph(A-c) L-eu A-rg P-ro-D A-la10 (212) Mo-rp-hol-inyl-CO D N-al-! D C-pa-D P-he S-er M-op-D A ph(Ac) L-eu A-rg P-ro- D A-la10
NH  NH
(213)Di i Pr NCO D Nal1 D Cpa D Phe Ser Mop D Aph( Ac)6 Leu Arg Pro D Ala10 (213) Di i Pr NCO D Nal1 D Cpa D Phe Ser Mop D Aph( Ac)6 Leu Arg Pro D Ala10
NH NH
(214)Di-Et-NCO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac )6-Leu-Arg-Pro-D-Ala10-NH - - -- -(214) Di-Et-NCO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)6-Leu-Arg-Pro-D-Ala10-NH - - -- -
(215)Ben-zo-y1 D-Na-1! D-Cp-a D-Phe-Ser'-Mo-p D Aph(-Ac) -L eu -Arg -Pr-o D A-la1 NH (215) Ben-zo-y1 D-Na-1! D-Cp-a D-Phe-Ser'-Mo-p D Aph(-Ac) -L eu -Arg -Pr-o D A-la1 NH
(216)CHF D NarD Cpa D Phe Ser Mop D Aph(Ac)6 (216)CHF D NarD Cpa D Phe Ser Mop D Aph(Ac)6
Leu Arg Pro D AlaI NH Leu Arg Pro D AlaI NH
(217)MOB-A--D-Na1-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph(Ac)--Leu- -Arg-8-Pro-9--D-Ala-10-NH  (217) MOB-A--D-Na1-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph(Ac)--Leu--Arg- 8-Pro-9--D-Ala-10-NH
(218)CPF D-N-a1' D-C-pa'D-P-he'S-er' M-op' D-A-ph(Ac)-L-eu Arg-Pro a0 (218) CPF D-N-a1' D-C-pa'D-P-he'S-er' M-op' D-A-ph(Ac)-L-eu Arg-Pro a0
-D Al-1 N-H- - -D Al-1 N-H- -
(219)NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di n But -yl) -Leu -Arg -Pr-o D A-la10(219) NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di n But -yl) -Leu -Arg -Pr-o D A-la10
NH  NH
(220)NH-CO-D Nal-1 D-Cp-a D-Ph-e Se-r-Mop-D Up-h(Pro 6 (220) NH-CO-D Nal-1 D-Cp-a D-Ph-e Se-r-Mop-D Up-h (Pro 6
-py-l) Leu -Arg -Pro -D Ala-10-NH - -py-l) Leu -Arg -Pro -D Ala-10-NH -
(221)Di n Butyl NCO D Nal! D Cpa D Phe Ser Mop D Ap h(Ac) Leu Arg Pro9(221) Di n Butyl NCO D Nal! D Cpa D Phe Ser Mop D Ap h(Ac) Leu Arg Pro9
D Ala1 NH D Ala1 NH
(222)Bu-ty-ryl-D--N-ar-D--C-pa-D--Phe--Ser--M-op-D-Aph(Butyr y1-)-Le-u-Ar-g8-Pr-o--D-Al-a10-NH  (222)Bu-ty-ryl-D--N-ar-D--C-pa-D--Phe--Ser--M-op-D-Aph(Butyr y1-)-Le-u-Ar -g8-Pr-o--D-Al-a10-NH
(223)Ac-D-Nal1-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Pelargony-l ) -Leu -Arg -Pr-o D A-la10 (223)Ac-D-Nal1-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Pelargony-l) -Leu -Arg -Pr-o D A-la10
NH  NH
(224)Ac D-Na-l1 D-Cp-a D-Ph-e Se-r Mo-p D-Ap-h(Butyr-yl) Leu-Arg- 9 (224)Ac D-Na-l1 D-Cp-a D-Ph-e Se-r Mo-p D-Ap-h(Butyr-yl) Leu-Arg- 9
Pro-D Al-a1-0 Pro-D Al-a1-0
NH - NH -
(225)NHCO D Nal1 D Cpa D Phe Ser'Mop D Uph(di Penty 1) Leu Arg Pro D Ala10(225)NHCO D Nal1 D Cpa D Phe Ser'Mop D Uph(di Penty 1) Leu Arg Pro D Ala10
NH  NH
$LVLikltL,&£L*ft&(I)-hJIk fA$LVLikltL, & £L*ft&(I)-hJIk fA
i tb (23),*(24*A i tb (23),*(24*A
), (25*), (26*),*i.a*'|i|tiitlJ (32), (38), (39), (41), (62), (63), (64), (65), (66), (67), (70), ( 1), ), ( ), ( ), ( ), ), ( 1), ( ) ( ), ( ) ( ), ( ), ( ) ( ), ( ), (1 ), (1 ), (1 ), (1 ) (11 ) (11 ), (11 ), (1 ) (1 ), (1 ) (1 1), (1 ), (1 ), 1 ), (1 1), 1 ), 1 )和(1 . 休 方式 ), (25*), (26*), *ia*'|i|tiitlJ (32), (38), (39), (41), (62), (63), (64), (65 ), (66), (67), (70), (1), ), ( ), ( ), ( ), ), ( 1), ( ) ( ), ( ) ( ), ( ), ( ) ( ), ( ), (1 ), (1 ), (1), (1) (11) (11), (11), (1) (1), (1) (1 1), (1), (1), 1), (1 1), 1 ), 1) and (1. Hugh way
在本 明中使用的 具有下面的 Used in the present invention with the following
c c
c 氨基 c amino
c 氨基 c amino
a a
p p
g g
ph 氨基 Ph amino
ph c) Ph c)
ph( e) ( , 二甲 ) 氨基 Ph( e) ( , dimethyl ) amino group
ph(Enanthy ) 氨基 Ph(Enanthy ) amino
ph Lau y ) 月桂 Ph Lau y ) Laurel
ph( a ty ) Ph( a ty )
ph(Bu y y ) Ph(Bu y y )
ph( co noy ) Ph( co noy )
ph( e a gony ) Ph( e a gony )
ph( Et) ( 二乙 ) Ph( Et) ( 二乙 )
ph( n P ) ( ) Ph( n P ) ( )
ph( n p opy ) ( , ) Ph( n p opy ) ( , )
ph( pe dy ) ( ) Aph(Morpho nyl-CO)- 4-(嗎琳甲銑腰基)苯丙氨酸 ph(Di--Pr)- 4-(N,N-二弄丙基脈基)苯丙氨酸 Uph(Di-Et)- 4-(N,N-二乙基脈基)苯丙氨酸 Ph( pe dy ) ( ) Aph(Morpho nyl-CO)- 4-(Molin-milled waist-based) phenylalanine ph(Di--Pr)- 4-(N,N-dipropylpropyl)phenylalanine Uph( Di-Et)- 4-(N,N-diethylcarbyl)phenylalanine
Enanthyl- 庚醜基Enanthyl- 庚丑
Lauryl- 月桂銑 Lauryl- Laurel Milling
Pal ityl- 棕櫚醜 Pal ityl- palm ugly
Butyryl- T銑基 Butyryl-T milling base
Nicotinoyl-炯醜基 Nicotinoyl-炯丑基
PelaIgonyl- 壬銑基PelaIgonyl- boring and milling base
Di-Et- 二乙基 Di-Et-diethyl
Di-n-PI- 二正丙基 Di-n-PI-di-n-propyl
Piperidyl - 派唳基 Piperidyl - 派基基
MoIpholinyl- 嗎琳基 MoIpholinyl-
Di-i-Pr 二弄丙基Di-i-Pr dipropyl
CHF- 杯己基甲銑基 CHF- cup hexyl milling
MOBA- 吋甲氧基苯乙銑基 MOBA- 吋 methoxy phenylethyl milling
CPF- 杯丙基甲銑基 CPF-cup propyl milling base
Asn- 天冬醜肢 Asn- Asparagus
Asp- 天冬氨酸Asp-aspartate
B c- 叔丁氧碳基 B c-tert-butoxy carbon
BOP- 苯井三哇-1-氧-三(二甲氨基)磷六氟磷酸 CAMBOP- benzene well three wow-1-oxy-tris(dimethylamino)phosphonium hexafluorophosphate CAM
J 浚甲基  J 浚 methyl
CEC- 梭乙銑基 CEC- shuttle
Cpa- 4-氯苯丙氨酸Cpa- 4-chlorophenylalanine
CPC- 梭丙銑基 CPC- Shuttle Milling
DCC- 二杯己基碳二亞腰 D EA e 二弄丙基乙腰 DCC- two cups of hexyl carbon dioxide waist D EA e 2 propyl propyl waist
G n- 谷氨銑腰 G n- glutamine milling
G u- 谷氨酸 G u- glutamic acid
HOBt P l-楚基苯井三哇HOBt P l-楚基苯井三哇
i-Pr P 弄丙基  i-Pr P propyl
Leu p 亮氨酸 Leu p leucine
Lys- 賴氨酸 Lys-lysine
Phe(COOH)- 梭基苯丙氨酸 Phe(COOH)- shuttle phenylalanine
Ph (CAM)- 梭甲基苯丙氨酸Ph (CAM)-choline methylphenylalanine
ILys , 弄丙基賴氨酸ILys , propyl lysine
Orn P 弄丙基冉氨酸  Orn P propyl valine
MBHA , 苯基氨甲基村脂 MBHA, phenylaminomethyl glutamate
Mob- B-胡椒基丙氨酸 Mob- B-piperonyl alanine
Mop p 嗎琳甲基苯丙氨酸Mop p morphine methyl phenylalanine
Mph- 胡椒基丙氨酸 Mph-piperonyl alanine
Na - 茶丙氨酸 Na - tea alanine
NTA N,N-二叛乙基氨基乙魷基 NTA N,N-di-alkatoethylaminoethyl
NTA - N,N-(二辛氧碳基甲基)氨基乙酸 NDN- N,N-(二氨基魷甲基)氨基乙銑基NDNt u- N,N-(二叔丁氨基銑甲基)氨基乙酸 P 3-毗咬丙氨酸 NTA - N,N-(dioctyloxycarbylmethyl)aminoacetic acid NDN- N,N-(diaminofluorenylmethyl)aminoethyl milling NDNut u- N,N-(di-tert-butylaminomethyl) Glycine P 3-azetyl alanine
Phe- 苯丙氨酸, Phe- phenylalanine,
RP-HPLC- 反相高效液相色借 RP-HPLC- reversed-phase high-performance liquid chromatography
PIo-SeI- TEA- 三乙腰 e doPIo-SeI- TEA- triple waist e do
p p
he( ) (( , ) ) He( ) (( , ) )
he( ) (( 氧碳 ) ) He( ) ((oxygen carbon) )
Fhe( ) (( , 氨基 ) ) Fhe( ) (( , amino ) )
he( t u ) (( , 氨基 ) ) he( ) (( , 二楚 ) ) He( t u ) (( , amino ) ) he( ) (( , 二楚 ) )
he( ) (( 氧 ) ) 除非另有 在本 中使用的木 具有以下 。  He( ) ((oxygen)) Unless otherwise used in this wood has the following.
本 明中, 所有氨基酸 注明 外, 均力 。 " "是 或 其中 的 本文中 。 In the present specification, all amino acids are indicated, and the same is true. " " Yes or one of them in this article.
" 氨基"是指 ,其中 的 本文中 。 " 氧基碳 "是指 , 其中 的 本文中 。  "Amino" refers to the text in which it is. "Alkyl carbon" refers to the text of this article.
性的 氧基碳 包括 氧基碳基和 氧基碳 。 除非另外 , " "是指直 或 的 中具有約 1 約 碳原子的 其 介或 素原子取代。 中具有 1 碳原子的 更化 健中具有 1 碳原子的 。 作力 介基因或低 氧基、 低 、 低 亞硫 或低 等的組成部分的 "低 " 是指直 或 的 中具有 1 碳原子的 , 除非 外 。 性的 包括 、 、 、 、  The oxycarbons include oxycarbyl and oxycarbon. Unless otherwise specified, "" refers to a substitution of a meso or alkene atom having about 1 about a carbon atom in a straight or a straight. The more normal one with 1 carbon atom has 1 carbon atom. A "low" that is a component of a gene or a low oxy group, a low, a low sulphur, or a low component refers to a straight one or one carbon atom unless otherwise. Sexuality includes , , , , ,
、 、 、 、 、 辛基、 、 基和十二 。 介或 素原子取代的 的 包括 。 可以 1 、 、 或 立地 自鹵素, 硝基, 氨基, , , 或 氧基或者 , , , , , , 辛基 , , Base and twelve. Substituted by a medium or a substituted atom. May be 1, or, or from a halogen, nitro, amino, , or oxy group or
的取代 取代。 Replacement of the substitution.
" "是指含有碳 碳 同 中具有約 約 碳原 子的直 或 的 。 中具有 1 碳原子的 , 更 中具有 碳原子 例 碳原子)。 在此 和 文本中所用的 "支鏈" 是指 介或 低 、 或 連接在直 上 在此是指直 。 "低 " 是指 中含有約 約 碳原子, 其可以是 或 的。  "" means a straight or a carbon-carbon having approximately a carbon atom. It has 1 carbon atom and has a carbon atom in the middle. The term "branched" as used herein and in the text refers to either "low" or "directly" or "directly connected". "Low" means that it contains about a carbon atom, which can be or .
性的 包括乙烯 、 丙烯 、 、 、 Sexuality includes ethylene, propylene, , ,
、 、 、 、 基和 。 可以 可以 1 、 、 或 立地 自 素 硝基, 氨基 , , 或 氧基或者 的 取代 取代。  , , , , , and . It may be substituted with 1, or , or a substitution of a nitro group, an amino group, or an oxy group.
" "是指含有碳 碳 , 同 是直 或 的 中具有 約 約 碳原子的 。 的 在 中具有 1 碳原子 和更 中具有 碳原子(例 碳原子)。  "" means carbon-carbon, which has about or about a carbon atom. It has 1 carbon atom and more has a carbon atom (for example, a carbon atom).
性的 包括 、 、 、 、  Sexuality includes , , , , ,
基和 。 可以 1 、 、 或 立地 素, 硝基, 氨基, , , 氧 基或者 的取代 取代。  Base and . It may be substituted by 1, or , or a nitro, amino, , or oxy group or a substitution.
" 氧基" 是指 0 , 其中 的 本文中 。 氧基的 包括 氧基、 氧基、 氧基、 氧基、 氧基、 氧基、 氧基和 氧基。  "Oxy" refers to 0, which is in this article. The oxy group includes an oxy group, an oxy group, an oxy group, an oxy group, an oxy group, an oxy group, an oxy group and an oxy group.
" "是指 , 其中 的 本文中 。 " 氧基"是指 0 , 其中 上。 的 氧基包括 氧基。 "" means, among them in this article. "Oxy" means 0, which is above. The oxy group includes an oxy group.
" " 是指 , 其中 上。  " " means , which is above.
" 素" 包括 、 、 和 , 、 或 。 "素" includes , , , and , , or .
" " 是指 , 其中 的 本文中 。 性的 包括苯甲 , 1 基和 。  "" refers to , among them in this article. Sex includes benzene, 1 base and .
" 氨基"是 , 其中 上。  "Amino" is , which is above.
" "作力 介基因或基因的組成部分代表 ) 1 碳原子的 取代的羊 或 族碳杯部分, 苯基或 或( ) 取代的部分飽和的 族碳杯部分, 其中 基和 或 合在 起 , 例 氧 、 或 氫 。 除非另外 , 可以 介或 ( 、 、 、 ) 取代 取代, 其可以相同或不同, 其 中 "芳基取代 " 包括, 例 、 氨基、 氧基、 氧基 碳 二氧基、 亞硫 、 、 、 、 氨基、 、 氧基、 氧基碳 、  "" is a component of a gene or gene that is represented by a component of a carbon or a substituted carbon or a portion of a carbon or a cup, a partially saturated saturated carbon cup portion substituted with a phenyl group or ( ), in which a group and a group are combined, For example, oxygen, or hydrogen. Unless otherwise, the substitution may be substituted by ( or , , , ) which may be the same or different, wherein "aryl substituted" includes, for example, amino, oxy, oxycarbodioxy, sulfite, , , , amino, , oxy, oxy carbon,
、 氧基、 氧基碳 亞硫 、 、 、 (或 生物等 )、 、 素、 、 、 氧基、 氨基、 氧基、 、 硝基、 、 , 例 素, 硝基, 氧基 , 氧基, , 亞磺 , , 氧碳 , 氨基, 氨基, 氨基或  , oxy, oxycarbosulfide, , (or biological, etc.), aryl, aryl, hydroxy, amino, oxy, nitro, nitro, nitro, oxy, oxy, Sulfin, oxycarbon, amino, amino, amino or
碳 氨基。 " 取代 " 中的基因具有本 明中 出的 。 Carbon Amino group. The genes in "replacement" have the ones in this book.
" 氧基" 是指 0 , 其中 上 。 性的 氧基包括 氧基和 1 氧基或 氧 基。 " "是指 , 其中 的 如上 。 性的 是 。 "Oxy" means 0, which is above. Alkoxy groups include oxy groups and 1 oxy or oxy groups. "" means that, among them. Sex is.
" 氧基"是指G基 0 , 其中 上 。 性的 氧 基包括 氧基和 氧基, 其各 任 取代。 "Alkyl" means G group 0, of which is above. The oxygen group includes an oxy group and an oxy group, which are each substituted.
" "是指含有至少 介碳 碳 具有約 約 1 碳原子的非 羊 或 杯杯 。 性的羊杯杯 包括  " " means a non-sheep or cup containing at least about 1 carbon atom. Sexual sheep cups included
、 基和 。 可以 1 、 、 或 立地 自 素, 硝基, 氨基, , 或 氧基的取代 取代。 , base and . It may be substituted by 1, or , or by a substitution of a nitro group, an amino group, or an oxy group.
" "是指 1 碳原子的飽和羊 或 杯杯  " " means a saturated carbon or cup with 1 carbon atom
氧取代。 性的羊杯杯 包括 ,, , 、 、 基和 。 可以 1 、 或 立地 素, 硝基, 氨基, , ,  Oxygen substitution. Sexual sheep cups include , , , , , and . Can be 1, or genomic, nitro, amino, , ,
或 氧基的取代 取代。Or a substitution of an oxy group.
" "是在其 中具有 介或多 ( 、 、 、 ) 原子的化合物。 的 原子包括氮( )、 氧(0)和 (5)。 基特別可以是 的 (也就是 )、飽和的或部分飽 和的。 本 化 的羊 包括 勻 羊 。  " " is a compound in which there are intermediates or poly ( , , , ) atoms. The atoms include nitrogen ( ), oxygen (0) and (5). The base can be (ie), saturated or partially saturated. The natural sheep include the uniform sheep.
和 族化合物近可 步 下 基因取代 素, 氧基, , 氧基, 硝基, 氧基 , 氨 基或苯基。  And the compound is close to the gene replacement, oxy, oxy, nitro, oxy, amino or phenyl.
本 的 或 的 包括 1 , 或 1 , 、 、 、 1 , 、 1  The sum of this includes 1 , or 1 , , , , 1 , , 1
1, 或 1, , 、 1, , 或 1, , , 二吐 、 、 、 1, , 、 或 、 、 1 或 、 、 或 、 -3- -4-或_ _基、 1,2,3-> 1,2 1,2 5 或 1, 3,4-嗯二 _ _ 哇 、 -4-或-5-基、 嗯四湊基、 嗯三嗓基、 1,2, 3,4-或 1,2, 3,5-嗯三哇 基、 嗯 9 -4-或-5-基、 2-或 3-毗嗓基、 1- 3-或 4-毗哇基、 3-或 4-吱嘻基、 3-或 4-毗咬基、 2- 4-或 _喀咬基、1, or 1, , , 1, , or 1, , , two spit, , , 1, , , or , , 1 or , , or -3- -4- or _ _ base, 1,2,3-> 1,2 1,2 5 or 1, 3,4- um two _ _ wow, -4- or -5-base, um Base, umsan, 1, 2, 3, 4- or 1, 2, 3, 5 - um, three wu, y, 9 or -4-, ke, 2- or 3-pyryl, 1 3- or 4-pywayl, 3- or 4-mercapto, 3- or 4-pyrylene, 2- 4- or _ carbyl,
2 或 3-毗咯基、 1,2, 3,4-或 2, 1, 3,4-四哇基、 喀二哇-3- -4- 或 喀哇-2- -4-或-5-基 2-或 吩基、 1,2,3- 1,2,4- 或 1, 3,5-三嗓基和 1,2 1,2 2, 1,3-或 4, 1,2-三哇基。 本友明最仇迭的芳族奈杯基包括吠喃-2-基、 吠喃-3-基、 2- 4- 或 5-咪哇基、 3- 4-或 _弄嗯哇基、 2-或 3-毗咬基和 1-或2-喀吩基。 2 or 3-pyrrolyl, 1,2, 3,4- or 2, 1, 3,4-tetrawayl, Kawarwa-3--4- or Kawa-2--4- or -5 -yl 2 or phenyl, 1,2,3- 1,2,4- or 1,3,5-trimethyl and 1,2 1,2 2, 1,3- or 4, 1,2- Three wow base. Ben Youming's most capricious aromatic nai cup base includes 吠-2-yl, 吠--3-yl, 2- 4- or 5-imicy, 3- 4- or _ 嗯 哇 哇, 2 -or 3-didentate and 1- or 2-carbo.
本友明化迭的飽和或部分飽和 或 6-元染杯基的奕例包括 1, 3,5,6,2-二嗯二湊基、 1,2, 3,4, _或 1,2, 3,5,4-二嗯二哇基、 二嗯燒基、 1, 3-二氧柴杯戊烯基、 1, 3,5,6,2-二嚷二嗓基、 1,2, 3,4,5-或 1,2, 3,5,4-二喀二咄基、 2-弄咪哇基、 弄毗咯基、 弄四哇基、1,2, 3-或 1,2,4-弄三哇基、嗎琳基、嗯二嗓基、1,2,4- 1,2,6-、 1, 3,2-、 1, 3,6-或 1,4,2-嗯嘻基、 呱嗓基、 高呱嗓基、 呱咬基、 1,2-、 1, 3-或 1,4-毗喃基和 1,2, 3-毗咯燒基。  Examples of saturated or partially saturated or 6-symbolized cup bases of this friend include 1, 3, 5, 6, 2, 2, 2, 2, 3, 4, _ or 1, 2 , 3,5,4- 嗯 二 哇 哇 二 二 二 二 二 二 二 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3,4,5- or 1,2,3,5,4-di-carbyl, 2-mimi-m, pyridine, sulphate, 1,2, 3- or 1,2 , 4-made three wow, morphine, um dimercapto, 1,2,4- 1,2,6-, 1, 3,2-, 1, 3,6- or 1,4,2-嘻 嘻, 呱嗓, 呱嗓, 呱, 1,2-, 1, 3- or 1,4-pyranyl and 1,2,3-pyrrolidyl.
"柴杯燒基"是指: (i)約 3-8元杯的杯燒基, 其含有 介或 多介染原子或迭自 0、 S和 NR R'的含染原子基因井且可以任卜迭地 被氧取代; (ii)部分飽和的多杯含朵原子碳杯部分, 其中芳基(或 染芳基)杯, 分別任迭地被 介或多介 "芳基取代基"取代, 井且 朵杯燒基稠合在一起枸成杯卜狀結枸 (此矣基因的奕例包括苯井二 氫毗喃基, 二氧苯井吠喃基,二氫叫味基和毗咯井[ ,2-a]毗咬基  "Chai Cup Burning Base" means: (i) a cup-burning base of about 3-8 cups containing a medium or a multi-dye atom or a dye-containing atomic well from 0, S and NR R' Substituted by oxygen; (ii) partially saturated multi-cup containing a portion of the atomic carbon cup, wherein the aryl (or aryl) cup is replaced by an intervening or poly-"aryl substituent", The well and the cup-burning base are condensed together into a cup-shaped knot. (Examples of this gene include benzene dihydropyridyl, dioxanthene, dihydrogen and pyrrole [ , 2-a]
根搪本友明,式( ) 「肢衍生物及其立休弄枸休和其元生理毒 不 在 激素分泌 中 良好效果, 而且在休 外測定中 較低的組 , 因此可作力激素 于 , 于哺乳 特別是 。 搪本本明明,式() "The limb derivative and its stagnation and its metaphysical toxicity It does not have a good effect in hormone secretion, and it is a lower group in the measurement of rest, so it can be used as a hormone, especially for breastfeeding.
本 因此 涉及含有作力活性成分的有效 量的至少 Therefore, it relates to an effective amount containing at least a working active ingredient
1) 衍生物和/或 休 休或 生理毒性 以及常規 賦形 或 的 物組合物。 "常規 賦形 或 " 包括任 或所有 , 分散 , 或 , 等 及 , 以及 似的生理配伍 , 以 合 注射, 肌肉注射, 皮下注射或其它 方式。 的方式, 可將 性化合物 以 化合物兔 或其它 然余 的影 而 。  1) Derivatives and/or rest or physiological toxicity as well as conventional shaped or composition compositions. "Regular shaping or" includes any or all, dispersion, or, etc., and similar physical compatibility, in combination with injection, intramuscular injection, subcutaneous injection or other means. The way, the sex compound can be seen as a compound rabbit or other.
本 所用木 " 生理毒性的 " 是指可保留 休化合物 預期生理活性而不 戶生任何意料 外 副作用的 或者它們的 合物。 例 , 氫 , 硫酸 , 磷酸 , 硝酸 以及醋酸 , 草酸 , , , 苯甲 , , 海藻 , 磺酸 , 磺酸 等。 中 含有的 子又可 , , , , , , 等 可 等有 。  The term "physiologically toxic" as used herein refers to a compound which retains the expected physiological activity of the compound without any unanticipated side effects or compounds thereof. For example, hydrogen, sulfuric acid, phosphoric acid, nitric acid and acetic acid, oxalic acid, , , benzoic acid, seaweed, sulfonic acid, sulfonic acid, etc. The sub-containing can be , , , , , , etc.
本 十 衍生物或 休 休或 生理毒性 或含有它的 物組合物可以以已知的任何方式 , 口服、 肌 肉、 皮下等, 給 例 、 、 、 嚼 、 、 、 、 微東 、 、 等。 可以是普通 制 、 、 及各科微粒 統。 了將羊  The ten derivative or the composition of the resting or physiological toxicity or the composition containing the same may be administered orally, muscle, subcutaneously, etc. in any manner known, for example, chewing, , , , , , , , , . It can be general system, and various micro-organisms. The sheep
, 可以 使用本領域 的各科生物可 的 或生物相容 休。 于 休的例子, 如 水 及各 沖水溶液、 乙醇或其它 元 、 休、 乳酸、 乙烯 、 、 、 等。 , can be used in various fields of the field biocompatible or biocompatible. Examples of Yuxi, such as water and various aqueous solutions, ethanol or other elements, Hugh, lactic acid, ethylene, , Wait.
本 (1) 衍生物或 休 休或 生理毒性 的 取決于 因素, 例如所要預防或治行疾病的性 和 程度, 患者或 物的性別、 年齡、 休 , 敏感性及 休反 , 所用的 休化合物, 給 往, 給 以及 希望 到的 效果等。 上 可以羊 形式或分成 , 例 二、 三、 形式 。 羊 最大 般不 g/ g休 例 如 . 1 g/ g休 , 1 g/ g休 , 較佳 固 . 9/ 9休 。 但是, 在某些情況下, 也可能使用 g/ g 休 以上或者 g/ g休 以下的羊 。  The (1) derivative or resting or physiological toxicity depends on factors such as the nature and extent of the disease to be prevented or treated, the sex or age of the patient or the substance, the sensitivity, and the reversal of the compound used, We give, and we give effect to hope. It can be in the form of sheep or divided into two, three, and three forms. The sheep are not as big as g / g . 1 g / g rest , 1 g / g rest , better solid . 9/9 off. However, in some cases, it is also possible to use g/g or above or g/g for the following sheep.
下面的 及生物活性 未 步 明本 , 但 不意味看 本 的任何限制。 The following and biological activities are not available, but do not imply any limitations of this.
所用固相合成 休 天津南 合成責任有 限公 B B 以及 oc 休 的天然氨基酸 由上海 生化公 以及成都 新 木有限責任公 , Boc 的非天然氨基酸 外均由本 合成提供。 1 , ( 氧碳 ) 氨基 [ ]的合成 二乙 ( . o1, 9) (1. 1, 9) 于 1 中, L 乙醇溶解。 下 The solid phase synthesis used in Tianjin Nanbei Synthetic Responsibility B B and the natural amino acids of oc Hugh are provided by Shanghai Biochemical Co., Ltd. and Chengdu Xinmu Co., Ltd., and Boc's unnatural amino acids are all provided by this synthesis. 1 , ( Oxycarbon) Synthesis of Amino [ ] Diethyl ( . o1, 9) (1. 1, 9) In 1 , L ethanol is dissolved. under
1 L, o ) 室溫 , 乙醇, 水溶液 至 , 再 水相 至酸性, 萃取, 水 兩次, 以 水硫酸 。 ,  1 L, o ) room temperature, ethanol, aqueous solution to, then aqueous phase to acidic, extracted, water twice, with water sulfuric acid. ,
得 9 , . L 氯仿 c( 1 . ), . 。 氧碳 二乙酸的合成Get 9 , . L chloroform c ( 1 . ), . . . Synthesis of oxycarbodiacetic acid
. g( . o1) 二乙 , L水, L 的 , L二氧 。 p , 1. g(Boc) 0( . o1, 于 L二氧 )。 反 中保持 , 1 除去二氧 ,水相 萃取 酸化至 p , 萃取 , 氯仿萃取 。 , ,得 1. 9白 固休。 . 1 g( . o1) Diethylene, L water, L, L dioxane. p , 1. g(Boc) 0( . o1, in L dioxin). In the opposite, 1 removed the dioxane, the aqueous phase was extracted and acidified to p, extracted, and extracted with chloroform. , , got 1. 9 white solid rest. . 1
= .5 水, ), p. 1 1 C。 氧碳 二乙 的合成  = .5 water, ), p. 1 1 C. Synthesis of oxycarbon diethylene
1 9( . o ) 氧碳 二乙 于 L 水 氫 中, 1 C下 . L , 1 9 ( . o ) Oxygen - carbon dichloride in L water hydrogen , 1 C lower . L ,
. L ( . O ) , , . L( . o1) 。 L , 原料已反 。  L ( . O ) , , . L( . o1) . L, the raw materials have been reversed.
氫 , , 去不 , 分別 碳酸氫 水 , 水 , 酸水 飽和食 水 水硫酸 。 , 石油 。得白 固休 1. 19, . . ( Hydrogen, , go, respectively, hydrogen carbonate water, water, acid water, saturated water, water, sulfuric acid. , oil. Get white and rest 1.19, . . (
1 . ), .p. 1 1 1°C。  1 . ), . p. 1 1 1 °C.
二乙 的合成 Synthesis of diethyl
g ( . o ) 氧碳 二乙 于 1 L / t c溶液中, 1 L , 原料已反 。  g ( . o ) Oxygen carbon Diethyl in 1 L / t c solution, 1 L, the raw material has been reversed.
, 得 9白 固休 . ( 氨基 ) 氨基 [ "]的合成 . 9 ( o1)的 二乙 于 L二氧 杯中, . L( 0 O )的 , 生成的 , . 9 (1 o1) 。 C 熱反 , , , L水, 酸化至 p , 用水 , 飽和 水 水硫酸 。 , , 得 1. 9 白 固休。 .1 。 .p. 1 1 C, TL ( , get 9 white solids. (Amino) amino [ [] synthesis . 9 ( o1 ) of the second in the L dioxygen cup, . L( 0 O ), generated, . 9 (1 o1). C heat reverse, , , L water, acidified to p, water, saturated water sulfuric acid. , , got 1. 9 White solid rest. .1 . . p. 1 1 C, TL (
水, 1 ) . 。 Boc p he的合成 Water1 ) . . Synthesis of Boc p he
c he(p ) he (本 按照常規方法制各, ( 9, 1. o1)于 L 和 L二氧 杯中回流 1 > 蒸去 和二氧 , 得到固休不 化直接在 下 L , 至 , 再 . o1 .g L), 然 . 9 (Boc) 0 ( 1.1 O ) 室溫 1  c he(p ) he (This method is prepared according to the conventional method, (9, 1. o1) is refluxed in L and L dioxygen cups 1 > evaporated and dioxin, which is obtained directly under L, to, and then .o1 .g L), of course. 9 (Boc) 0 ( 1.1 O ) room temperature 1
水溶液 至酸性, 萃取, 水 兩次 水硫 酸 。 , 石油 結晶 得 . 9 白 休, .1 L 氯仿 Aqueous solution to acid, extraction, water twice water sulfuric acid. The oil crystallizes . 9 white, .1 L chloroform
c( 1 . ) . 。 氧碳 ( 氧碳 ) c( 1 . ) . Oxygen carbon (oxygen carbon)
[Boc Phe( ) 的合成 Synthesis of [Boc Phe( )
1. 9 ( o ) Boc he . 9 (1 o1) 二乙 和 F混合, 回流反 h。 水  1. 9 ( o ) Boc he . 9 (1 o1) Diethyl and F are mixed and refluxed with h. Water
, 萃取。 飽和 a , 水硫酸 。 , ( 石油 , 1 1 1)。  , extraction. Saturated a, water sulfuric acid. , (oil, 1 1 1).
, 溶解 碳酸氫 水 , 酸水 , 飽和 水 , 水硫酸 。 , 石油 。 , 得白 固休 1. g9(常溫下 ,冰涼 固休), . TL , . (氯仿 , 1 . ). 氧碳 (NN 氨基 ), dissolved hydrogen carbonate water, acid water, saturated Water, water sulfuric acid. , oil. , got the white solid holiday 1. G9 (under normal temperature, cold and solid), TL, . (chloroform, 1 . ). Oxygen carbon (NN amino)
[ oc he( u ) ]的合成  Synthesis of [ oc he( u ) ]
將 1. 9 ( o1) Boc Phe 1. 9 (. o1) 二乙 、 . L( . o1) 和 L 混合, 熱 C , 反 。 停止反 蒸去 水, 酸化至 。 萃取。 飽和食 水 水硫酸 。 , , 石油 。 , 得白 固休 . 9, TL , . (氯仿 Will be 1. 9 ( o1 ) Boc Phe 1. 9 (. o1) . L( . o1) and L are mixed, hot C, and reverse. Stop de-steaming and acidify to acid. extraction. Saturated water, water, sulfuric acid. , , Oil. , get white and rest . 9, TL, . (chloroform
1 . ) p. °C。 氧碳 二乙醇的合成  1 . ) p. °C. Synthesis of oxycarbon diethanol
1. 9 (1 o1) 二乙醇, L水 L a L二氧 。 控制 p , . 9 (1 o1) (Boc) 0( 于 L二氧 )。反 中休 , 1 除去二 氧 , 水相 萃取 酸化至 , 萃取 萃取 。 , , 得 1. 9 。 . , . 1(氯仿 , 1 . ) 1 氧碳 二乙基辛 的合成  1. 9 (1 o1) diethanol, L water L a L dioxane. Control p , . 9 (1 o1) (Boc) 0 (in L dioxin). Anti-offset, 1 removes dioxane, extracts acid phase from aqueous phase, extracts and extracts. , , got 1. 9 . . , 1 (chloroform, 1 . ) 1 Synthesis of oxycarbon diethyl octane
1 9 ( O )的 氧碳 二乙醇 于 L T F 中, 1 C下分批 g9 (1 . o )的 a , . 9 ( . o1) 化 和 1. L (1 . o1) 化 , L 原料已反 , L水水解, T F L 水, 萃取, 水 , 飽和食 水 , 水硫酸 。 1 9 ( O ) of oxycarbon diethanol in LTF, batching g9 (1 . o ) at 1 C. 9 ( . o1) and 1. L (1 . o1), L raw material has been reversed, L water hydrolysis, TFL water, extraction, water, saturated water, water sulfuric acid.
, 石油 , 1 )得 1.1 9 。 , oil, 1) got 1.1 9 .
. , . 1( )。 11 二乙基辛 的合成  . , . 1( ). Synthesis of 11 diethyl octyl
1.1 9( .1 o )的 氧碳 二乙 于 1 / t c溶液中, 1小 L , 原料已反 。  1.1 9 ( .1 o ) of oxycarbonate in a 1 / t c solution, 1 small L, the raw material has been reversed.
, 得 1. 9白 固休 . 氧碳 ( 氧 , get 1. 9 white solid rest. Oxygen carbon (oxygen
[Boc he( ) ]的合成 Synthesis of [Boc he( ) ]
.1 9 . o1) Boc Phe . 9 .1 o1) 二乙 千 、 . L( . o ) 和 L 混合 熱 C , 反 。 停止反 , 蒸去 , 水, 酸化至 。 萃取。 飽和食 水 , 水硫酸 。 , , (氯仿 , 1 . )得 . 9 。 1. , . (氯仿 .1 9 . o1) Boc Phe . 9 .1 o1) Two thousand thousand , . L( . o ) and L mixed with heat C, inverse. Stop the reverse, steam, water, acidify to. extraction. Saturated water, water sulfuric acid. , , ( chloroform , 1 . ) 9 . 1. , . (chloroform
1 . ). 1 " 氧碳 千  1 . ). 1 " Oxygen carbon thousand
[Boc Ly (Bz ) ]的合成Synthesis of [Boc Ly (Bz ) ]
L反 內 Boc Ly ( ) . 9, 1 P . 9, L 水 , kg/c , 溫度 C, 反 h。 , 下 L 苯甲 , 9 1 d 和 L 水 , kg/c , 溫度 C反 h。 , 走 , 下 L , , 下飽和 a , p , 萃取 余的 苯甲 , 水相 酸調 , 萃取 合井 相, 水 ,L anti-inner Boc Ly ( ) . 9, 1 P . 9, L water, kg/c, temperature C, anti-h. , L L benzo, 9 1 d and L water, kg / c, temperature C anti h. , go, down L , , lower saturation a , p , extraction of residual benzene, aqueous acid adjustment, extraction of well phase, water,
)。 , 結晶, 得白 固休 9, . TL , = . (氯仿 ). , crystallization, whitening, solid, 9. TL, = . (chloroform
, 1 1). 1 " 氧碳 氧碳 辛基  , 1 1). 1 " Oxycarbon Carbon Oxygen Octyl
[Boc Ly (Bz F oc) ]  [Boc Ly (Bz F oc) ]
Boc Ly (Bz ) ( . 9, . o1)溶解于 1 0中, a 溶液 p 1 , L ox L ox 溶解 F oc u( . 9, . 1 1. ), 緩慢 加 休 , 羊 , 保持 常溫下反 。 走 o , 水 至 L 萃取 , p ,  Boc Ly (Bz) ( . 9, . o1) is dissolved in 10, a solution p 1 , L ox L ox dissolves F oc u ( . 9, . 1 1. ), slowly increases rest, sheep, keeps at room temperature anti. Go o, water to L extraction, p,
萃取, 合井 相, 飽和 a , 水硫酸 。 , , 1), 得 , 石油 固休, 水 / 結晶, 得 . 1 9。 . 。 L , . (氯仿 醋酸, 1 . ). 1 " 氧碳 ( 氧碳 )Extraction, well phase, saturation a, water sulfuric acid. , , 1), get, oil, rest, water / crystallization, get. 1 9. . . L , . ( chloroform acetic acid , 1 . ) . 1 " oxygen carbon ( oxygen carbon )
[ oc p(F oc) ]  [ oc p(F oc) ]
下往 L 水 中 , n,使 到 飽和。 1 L d Z 溶解 Boc he ( 9, . o1),分批 飽和 / e 中, 保持 , 度及低溫余 下反 h以 上, 監測(氯仿 醋酸, 1 . )反 完全  Down to L water, n, to saturate. 1 L d Z Dissolve Boc he ( 9, . o1), batch saturation / e, hold, degree and low temperature residual anti-h or more, monitor (chloroform acetic acid, 1 . )
, 常溫 , , 得 固休直接 于下 步反 。 L . ( 醋酸 水, 1 1). 將上 步反 所得 溶解于 L水中, 下 1 a , p , L二氧 , L二氧 溶解 F oc . 9, . ), 休 。 下 反 , 常溫反 。 L水, 萃取 , normal temperature, , Deguxiu directly in the next step. L. (Acetic acid water, 1 1). The upper step is dissolved in L water, the lower 1 a, p, L dioxane, L dioxygen dissolved F oc . ), Hugh. Reverse, normal temperature is reversed. L water, extraction
下 酸調 p , 萃取, 合井 相, 依次用水, 飽 和 a , 水硫酸 。 , , ( Et c, 1 1 前端 e c, 1 . )。  Under acid adjustment p, extraction, well phase, followed by water, saturated a, water sulfuric acid. , , ( Et c, 1 1 front end e c, 1 . ).
, 得 固休 1. 9。 . TL f . (氯 仿 醋酸, 1 . ) 1 化合物(1 )的合成  , have a fixed time 1. 9. TL f . (chloroform acetic acid, 1 . ) 1 Synthesis of compound (1)
以 ( . o1) 固相 休, B / 合 , 化合物的氨基酸序列, 的 Boc 固相 合成方法 (參考 惟 著, 合成, 出版社, 1 ) 操 作 合 成 c a pa he e n op Leu g o a B 。  The solid phase synthesis of (.o1), the B/H, the amino acid sequence of the compound, and the Boc solid phase synthesis method (cf., synthesis, press, 1) operate to synthesize c a pa he e n op Leu g o a B .
將上 放 F切割 的反 器中, 1. L苯甲 , 裝好 特 F切割 的休 , 氮 反 , Will put the F-cut counter, 1. L benzophenone, loaded with special F-cut Hugh, nitrogen counter,
1 L F, 于 C反 。 用油泵抽走 F, 取下反 , 水 固休 再將 特移至 漏斗中。 少量 的元水 三次, 再用 1 的 酸水溶液沖洗至 不再相互 ,收集 , 得 . 9白 ,1 L F, in C reverse. Use the oil pump to remove F, remove the reverse, and then move the water to the funnel. A small amount of water is used three times, then rinsed with 1 acid aqueous solution until they are no longer collected from each other. 9 white,
. 。 P L 化得 1. . . . P L is 1.
B 1 . ( 1 .1). 1 大 休 抑制 作用 B 1 . ( 1 .1). 1 big break inhibition
前 休 , 玻璃毛細管 , 血清 用化學友光法測定血清 含量, 含量和休 隨和分組 只 ,分別于 次 皮下注射或 化合物(不 同 ) 、1 等, , p Q n 將 得到的血清用化 光法 ( eck an ou te 公 cce unoa ay y te 化 )測定血清 含量。 1 促使大 腹腔肥大細胞 的能力測定 只雄性大 放血 , 腹腔注射 B L/只, 腹腔 腹腔 至 中 1 p 1 ,  Premature vaccination, glass capillary, serum by chemical light method for determination of serum content, content and rest and grouping only, subcutaneous injection or compound (different), 1, etc., p Q n will be obtained by using the sera ( eck an ou te public cce unoa ay y te)) Determination of serum content. 1 The ability to induce large abdominal mast cells is measured by male bloodletting, intraperitoneal injection of B L / only, abdominal cavity to the middle 1 p 1 ,
次 合井 細胞, 將 羊細胞 , 細胞稀釋 倍 有 細胞 。 上 細胞 分別 不同的 C 有 1 , 煮沸 終止反 。  In the secondary well cells, the sheep cells and cells are diluted with cells. The upper cells have different C, and the boiling stops.
上 B 公 的化 于 E n E n 測定 強度 強度 的 百分率,  The upper B is converted to the percentage of intensity strength measured by E n E n ,
物的 E  E
Figure imgf000045_0001
Figure imgf000046_0001
Figure imgf000047_0001
Figure imgf000048_0001
Figure imgf000045_0001
Figure imgf000046_0001
Figure imgf000047_0001
Figure imgf000048_0001
Figure imgf000049_0001
Figure imgf000049_0001
a 皮下 ug/ g b 服 1 g/kg  a subcutaneous ug/ g b serving 1 g/kg
# B 太高 # B too high
> 未 到抑制活性  > no inhibitory activity

Claims

要求 1. (U「tk衍生物或 休 休或 生理毒性 , pa aa e aa, a a ' a o a 其中,Requirements 1. (U "tk derivative or resting or physiological toxicity, pa aa e aa, a a ' a o a
( ) ( ) ( ) ( ) 、 P( ) ( ) ( ) ( ) ( ) > ( ) ( ) ( ) ( ) ( ) ( ) , P( ) ( ) ( ) ( ) ( ) > ( ) ( )
( )  ( )
、 ,、 ,和 相互 立地分別 , 含有或不含有  , , , , and mutually separate, with or without
、 磷酸 、 的取代或未取代的 ,直 或  , substituted or unsubstituted, phosphoric acid, straight or
取代或未取代的 , , 直 或 或者 , 取代或未取代 的 ,直 或 氧基,取代或未取代的 ,直 或 Substituted or unsubstituted, straight or or, substituted or unsubstituted, straight or oxy, substituted or unsubstituted, straight or
, 取代或未取代的 , 直 或 , 取代或未取代 的 , , 直 或 氧基或者 氧基, 取代或未取代的 , ,直 或 或者 , 取代或未取代的 , 直 或 或者 , 或 ( ,) , Substituted or unsubstituted, straight or substituted or unsubstituted, straight or oxy or oxy, substituted or unsubstituted, straight or or substituted or unsubstituted, straight or or, or (,) ,
( ,) , ( ,) , ( , 或  ( ,) , ( , ) , ( , or
其中 、 、 磷酸 、 是 介或 p 分別 立地連接在 、 ,、 和 的任何 介碳原子上  Wherein, phosphoric acid, mediated or p are respectively attached to any of the carbon atoms of , , , and
t、 n和 p分別 立地 的  T, n, and p respectively
, ( ), ( ), ( v)或(v)
Figure imgf000051_0001
, ( ), ( ), ( v) or (v)
Figure imgf000051_0001
立地 的 Site
,和 , ,相互 立地分別 取代或未取代的 , 直 或 , 取代或未取代的 , , 直 或 或者 , 取代或未取代的 , 直 或 氧基 取代或未取代的 ,直 或 , 取代或未取代的 , 直 或  , and, respectively, substituted or unsubstituted, straight or substituted or unsubstituted, straight or or substituted or unsubstituted, straight or oxy substituted or unsubstituted, straight or substituted or unsubstituted Direct or
, 或 ( ,) , ( ,) , ( ,) , ( ,) , q 立地 的  , or ( , ) , ( , ) , ( , ) , ( , ) , q
、 c ( 、 D E nanthy 、 Laury 、 Pa y 、 Bu y y 、 cot noy 、 Pe a gony n > p pe y 、 o pho ny 、 或 t B g ,  , c ( , D E nanthy , Laury , Pa y , Bu y y , cot noy , Pe a gony n > p pe y , o pho ny , or t B g ,
,相互 立地分別 、 取代或未取代的 ,直 或 "  Reciprocal , substituted or unsubstituted, straight or "
取代或未取代的 , , 直 或 或者  Substituted or unsubstituted, , straight or or
或未取代的 , 直 或 氧基, 取代或未取代的 直 或 , 取代或未取代的 , 直 或 , 或 ( ) , ( ,) , ( ,) , Or unsubstituted, straight or oxy, substituted or unsubstituted straight or substituted or unsubstituted, straight or Or ( ) , ( , ) , ( ,) ,
( ,) 或 , q 立地 的整數, 例如 0, 1, , , , 或 ( ,) or , q an integer of the place, such as 0, 1, , , , or
, aa P e或 P aa , aa 和 aa 各 立地 L 或 型的 Ph ( )> he( ) phe( ) ph( c) op phe ph p ph g> o u p n n Ly y n o n t 或者 ph中的任何  , aa P e or P aa , aa and aa each of the L or type of Ph ( )> he( ) phe( ) ph( c) op phe ph p ph g> o u p n n Ly y n o n t or any of ph
或者 or
aa , aa 或 aa 相互 立地力以下 ( )或 (1 1)的  Aa , aa or aa stand below each other ( ) or (1 1)
Figure imgf000052_0001
> ( ) ( ) ( ) ( ( ) ( ) ( ) ( ) ( ) ( )P( ) ( ) "或
Figure imgf000052_0001
> ( ) ( ) ( ) ( ( ) ( ) ( ) ( ) ( ) ( )P( ) ( ) " or
> ( ( ) > ( ( )
( ) 、 ( ) 或  ( ), ( ) or
立地 的整數 相互Site integer Mutual
" " 立地分別 ( ) 、 , (0) , , ( ) , 其中, ,和 , 分別 , 取代或未取代的 直 或 , 取代或未取代的 , 直 或 或者 , 取代或未取代的 0直 或 氧基, 取代或未取代的 , 直 或 , 或 ( ,) ,  " " , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Base, substituted or unsubstituted, straight or, or ( ,) ,
( ,) , ( ,) , ( ,) , 或 , n 立地 的 ( , ) , ( , ) , ( , ) , or , n
aa化 he( ) he( ) phe( )> ph( c) op he ph p P o ph g n n u p phe( ) 或 h ( ) Aaization he( ) he( ) phe( )> ph( c) op he ph p P o ph g n n u p phe( ) or h ( )
aa he( ) he( ) he( ) ph( c) o p op he ph ph g n n u p h ( ) he( ) ph(Lau y ) D p ( a y ) D p (Buty y ) ph( cot noy ) p ( e a gony ) ph( ) ph n P ) p (P pe dy 、 ph( o pho ny ) ph( P ) ph( E ) Aa he( ) he( ) he( ) ph( c) op op he ph ph gnnuph ( ) he( ) ph(Lau y ) D p ( ay ) D p (Buty y ) ph( cot noy ) p ( ea gony Ph( ) ph n P ) p (P pe dy , ph( o pho ny ) ph( P ) ph( E )
aa化 g Ly n n或 n 和 aa Leu, c 或 c 其中, 中 1 ( 1 ) 立地 、 和 的 原子的 基因 未取代的 或 立地 自 素, 硝基, 或 的取代 羊取代或 取代或 取代的 、 、 或 羊 或 芳香基因, 苯基 或者 未取代的或 立地 自 鹵素, 硝基, 或 的取代 羊取代或 取代的、含有 1 立地 自 、 和 的 原子的 、 、 或 羊 或 芳香基因, Aa of g Ly nn or n and aa Leu, c or c wherein, 1 (1) of the site, and the atom of the gene is unsubstituted or substituted by a nitro group, or a substituted sheep, substituted or substituted, , or sheep or aromatic gene, phenyl or unsubstituted or standing from halogen, nitro, Or substituted or substituted, containing, or a sheep or an aromatic gene,
, , 。 . 要求 1 的 (1)十 衍生物或 休 休或 生 理毒性 aa, aa或 aa相互 立地力以下 ( )或 1 ) 的  , , . . Requires 1 (1) of the ten derivatives or rest or physiological toxicity aa, aa or aa mutual standing force () or 1)
Figure imgf000054_0001
( ) - ( ) ) > ( ( ) ( ) ( ) ( )P( ) P( ) " (
Figure imgf000054_0001
( ) - ( ) ) > ( ( ) ( ) ( ) ( )P( ) P( ) " (
( ) 6 ( ) 9 0) 、 (0)  ( ) 6 ( ) 9 0) , (0)
立地 的整數  Site integer
相互 mutual
" " 立地分別 0 、 , ( ) " " Sites 0 , , ( )
( ) , 其中, 和 , 分別 , 取代或未取代的 , 直 或 , 取代或未取代的 , 直 或 或者 , 取代或未取代的 , 直 或 氧基, 取代或未取代的 , 直 或 , 或 ( ,) ,  ( ), where, and, respectively, substituted or unsubstituted, straight or substituted or unsubstituted, straight or or, substituted or unsubstituted, straight or oxy, substituted or unsubstituted, straight or, or ,),
( ,) , ( ) , ( ,) 或 , n 立地 , 1, , 或 。 3 - f; J- -- -- - - -- - - -. -#-4cM-' i.( ,) , ( ) , ( , ) or , n Site, 1, , or . 3 - f; J- -- -- - - -- - - -. -#-4cM-' i.
--*#1J&2 (I)tWi i --*#1J&2 (I)tWi i
-- -- - - -- M) -- -- - - -- M)
- -? - (-l)-Ac D-Nal' D Cpa D Pal Ser Arg D Pal Leu Arg P s ro D Al 10 - -? - (-l)-Ac D-Nal' D Cpa D Pal Ser Arg D Pal Leu Arg P s ro D Al 10
a NH  a NH
(2)NH CO D Na D Phe Ser Arg (2) NH CO D Na D Phe Ser Arg
0 rD Cpa D Pal Leu Arg 9 0 rD Cpa D Pal Leu Arg 9
Pro D A  Pro D A
(3)N-l 1 (3) N-l 1
a a
H -NH- N -- - - -- - -6 - - - - CO D al' D Cpa D Pal Ser Arg D Pal Leu Arg Pro D Al 10 H -NH- N -- - - -- - -6 - - - - CO D al' D Cpa D Pal Ser Arg D Pal Leu Arg Pro D Al 10
-a-NH-- -- - - ---6 - - -0 -(-4)D-N-ar-D-Cpa-D-Phe-Ser-Gln-D Pal-Leu-Arg- 9 -a-NH-- -- - - --6 - - -0 -(-4)D-N-ar-D-Cpa-D-Phe-Ser-Gln-D Pal-Leu-Arg- 9
Pro- 0  Pro- 0
D-Ala!-NH  D-Ala!-NH
(5 -- -- )D-N- - - -- -- D C - - - pa D Pal Ser G 9 ln D Pal Le (5 -- -- )D-N- - - -- -- D C - - - pa D Pal Ser G 9 ln D Pal Le
?-al' u Arg Pro D Al l ?-al' u Arg Pro D Al l
a NH  a NH
(6)Ac D-N- al1 D-C- pa D-P- he S- er G- ln D- - P- al Leu A- -9 -- - rg P ro D Al 1 (6)Ac D-N- al1 D-C- pa D-P- he S- er G- ln D- - P- al Leu A- -9 -- - rg P ro D Al 1
a NH  a NH
(7)Ac D NarD Cpa D Pal Ser Gln D Pal Leu Arg P ro D Ala'  (7)Ac D NarD Cpa D Pal Ser Gln D Pal Leu Arg P ro D Ala'
(8)NH-NH-- -- -- - - -- - CO D Na (8)NH-NH-- -- -- - - -- - CO D Na
10 rD Cpa D Phe Ser Gln D Pal Leu Arg 9 10 rD Cpa D Phe Ser Gln D Pal Leu Arg 9
Pro D Ala N Pro D Ala N
(9)NH-C0-D-H (9) NH-C0-D-H
-N- - a1'-D- - C-pa-D-Pa - 1-Se - r-G- In-D- -- - - 6- Pa1- - Leu-Arg -Pro-D-Ala10-NH  -N- - a1'-D- - C-pa-D-Pa - 1-Se - r-G- In-D- -- - - 6- Pa1- - Leu-Arg -Pro-D-Ala10-NH
(lOD Nal' D Cpa' D Phe Ser Asn' D Pal' Leu' Arg Pro D Al l (lOD Nal' D Cpa' D Phe Ser Asn' D Pal' Leu' Arg Pro D Al l
a NH  a NH
(11)D Na1' D Cpa D Pa1 Ser Asn D Pa1 Leu Arg Pro D Al l (11)D Na1' D Cpa D Pa1 Ser Asn D Pa1 Leu Arg Pro D Al l
a NH  a NH
(12)Ac-D-Nar-D-Cpa-D-Phe-Ser-Asn-D- 6 (12)Ac-D-Nar-D-Cpa-D-Phe-Ser-Asn-D- 6
Pal-Leu-Arg- 9 -- -- -- - - -- - - - Pro--D--Ala10--NH Pal-Leu-Arg- 9 -- -- -- - - -- - - - Pro--D--Ala10--NH
(13)Ac D-Na-1' D-Cp-a D-Pa-1 Se-r As-n D-Pa-1 Le-u Ar-g Pr-o D-Al-a10 NH- (13)Ac D-Na-1' D-Cp-a D-Pa-1 Se-r As-n D-Pa-1 Le-u Ar-g Pr-o D-Al-a10 NH-
(14)NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Asn-D-Pal-Leu-Arg-Pro-D-A 0(14) NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Asn-D-Pal-Leu-Arg-Pro-D-A 0
la1 NH La1 NH
?- ?-
(15)N-H CO-D-Na1!-D-Cpa -D Pa1-Ser--Asn -D Pa1-Leu-Ar - g-Pro -D Ala' NH (15) N-H CO-D-Na1!-D-Cpa -D Pa1-Ser--Asn -D Pa1-Leu-Ar - g-Pro -D Ala' NH
(16)D NarD C 6 (16)D NarD C 6
pa D Phe Ser Mph D Pal Leu Arg Pro D Alal NH Pa D Phe Ser Mph D Pal Leu Arg Pro D Alal NH
(17)D--Na-r-D--Cp-a-D--Pa-l-Se-r-Mp-h-D--Pa-l-Le-u-Ar-g-Pr-o -D-A-la-l-NH- (17) D--Na-rD--Cp-aD--Pa-l-Se-r-Mp-hD--Pa-l-Le-u-Ar-g-Pr-o-DA-la-l -NH-
(18)Ac-D Na1' D Cpa D Phe-Ser-Mph(18)Ac-D Na1' D Cpa D Phe-Ser-Mph
0 - -- -- -D-Pal-Leu-Arg- Pro-D-Ala1-NH  0 - -- -- -D-Pal-Leu-Arg- Pro-D-Ala1-NH
(19)Ac D-Na-rD-Cp-a D-Pa-l Se-r Mp-h D-Pa-l Le-u Ar-gPr-o D-Al-a10 (19)Ac D-Na-rD-Cp-a D-Pa-l Se-r Mp-h D-Pa-l Le-u Ar-gPr-o D-Al-a10
NH- NH-
(20)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Ar g- 9(20) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mph-D-Pal-Leu-Ar g- 9
Pro-D-Ala10-NH  Pro-D-Ala10-NH
(21)NH CO D Na1' D Cpa D Pa1 Ser Mph D Pa1 Leu Ar g Pro D Ala1 NH (21) NH CO D Na1' D Cpa D Pa1 Ser Mph D Pa1 Leu Ar g Pro D Ala1 NH
(22)Ac--D--Na1'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg-- Pro--D--Ala10--NH  (22)Ac--D--Na1'--D--Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg-- Pro--D--Ala10 --NH
(23)Ac D Na1' D-Cpa-D-Phe-Ser-Aph-D 6 (23)Ac D Na1' D-Cpa-D-Phe-Ser-Aph-D 6
- -Mop-Leu-Arg 9 -- - Pro-D-Ala10 - -Mop-Leu-Arg 9 -- - Pro-D-Ala10
-NH  -NH
(24)Ac D Na a D Phe Ser' Uph D Mop Leu Arg (24)Ac D Na a D Phe Ser' Uph D Mop Leu Arg
0 0
Pro D Ala1 rD CpPro D Ala1 rD Cp
NH  NH
(25)Ac-D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu- -- -- -- - - -- - A 8 - rg--P 9(25)Ac-D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu- -- -- -- -- -- -- - A 8 - rg--P 9
ro--D--Ala10--NH ro--D--Ala10--NH
6  6
(26)Ac-D-Nal' D-Cpa'-D-Phe'-Ser'-Phe(NNM)-D-Mop-Leu- A 0 - rg-Pro-D-Ala1-NH  (26)Ac-D-Nal' D-Cpa'-D-Phe'-Ser'-Phe(NNM)-D-Mop-Leu- A 0 - rg-Pro-D-Ala1-NH
(27)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-6 (27)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-6
Leu-Arg-Pro--D Ala-10 Leu-Arg-Pro--D Ala-10
NH  NH
(28)Ac-D-Nar-D-Cpa-D-Phe-Ser'-Aph(A 6 (28)Ac-D-Nar-D-Cpa-D-Phe-Ser'-Aph (A 6
c) -D M-op -Leu -A rg -Pro -D-Ala10-NH  c) -D M-op -Leu -A rg -Pro -D-Ala10-NH
(29)Ac D Nal1 D Cpa D Phe Ser Aph(DMe) 6 (29)Ac D Nal1 D Cpa D Phe Ser Aph(DMe) 6
D Mop Leu Arg Pro D Ala10 D Mop Leu Arg Pro D Ala10
NH NH
(30)D-Nar-D-Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg--Pro9 - -D--Alal - -- --NH  (30) D-Nar-D-Cpa--D--Phe--Ser--Phe--D--Mop--Leu--Arg--Pro9 - -D--Alal - -- --NH
(31) 9 D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg-Pro-D-Alal-NH  (31) 9 D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg-Pro-D-Alal-NH
(32)D-Nal'-D-Cpa-D-Phe-Ser-Uph D Mo-p-Leu-Arg-Pro -D Al-al-NH - (32) D-Nal'-D-Cpa-D-Phe-Ser-Uph D Mo-p-Leu-Arg-Pro-D Al-al-NH -
(33)D-Nal' D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu-Arg -Pro-D-Ala10 - -NH (33) D-Nal' D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu-Arg-Pro-D-Ala10 - -NH
(34)D Nal1 D Cpa D Phe Ser Phe(NOM) D Mop Leu Arg Pro D Ala10 (34)D Nal1 D Cpa D Phe Ser Phe(NOM) D Mop Leu Arg Pro D Ala10
NH NH
(35)D--Nal1--D--Cpa--D--Phe--Ser--Aph(Ac)--D-M-o 6 (35) D--Nal1--D--Cpa--D--Phe--Ser--Aph(Ac)--D-M-o 6
p--Leu--Arg --P 9 p--Leu--Arg --P 9
ro--D--Ala!0--NH  ro--D--Ala!0--NH
(36)D Na - er Ap (36)D Na - er Ap
-Pro -D-A 10rD Cpa--D Phe--S -h(D-Me) -D-Mop-Leu-Arg 9 - la -NH  -Pro -D-A 10rD Cpa--D Phe--S -h(D-Me) -D-Mop-Leu-Arg 9 - la -NH
(37)NH CO D NarD Cpa D Phe Ser Phe D Mop Leu Ar 9 (37) NH CO D NarD Cpa D Phe Ser Phe D Mop Leu Ar 9
g Pro D Ala10g Pro D Ala10
NH  NH
(38)NH CO-D-Nal'-D-Cpa'-D-Phe'-Ser'-Aph'-D-Mop'-Leu'-Ar 9 -- -- -- - - -- - - g--Pro--D--Ala10--NH(38) NH CO-D-Nal'-D-Cpa'-D-Phe'-Ser'-Aph'-D-Mop'-Leu'-Ar 9 -- -- -- - - -- - - g--Pro--D--Ala10--NH
6  6
(39)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Uph D Mo-p-Leu-Ar g- 9 (39) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Uph D Mo-p-Leu-Ar g- 9
Pro-D Al-a1-0 Pro-D Al-a1-0
NH - NH -
(40)NH CO-D-Na(40) NH CO-D-Na
1r-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu-Arg-Pro-D-A 0 1r-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Leu-Arg-Pro-D-A 0
la-NH  la-NH
(41)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Le u-Arg- 9 (41) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Le u-Arg- 9
Pro-D-Ala1-NH  Pro-D-Ala1-NH
(42)NH CO D Nal' D Cpa D Phe Ser Phe(NOM) D Mop Le u Arg Pro D Ala10 (42) NH CO D Nal' D Cpa D Phe Ser Phe (NOM) D Mop Le u Arg Pro D Ala10
NH NH
(43)NH CO--D--Nar--D--Cpa--D--Phe--Ser'--Aph(Ac)--D-M-op--Leu --Arg--Pro--D-A-la1--NH  (43) NH CO--D--Nar--D--Cpa--D--Phe--Ser'--Aph(Ac)--DM-op--Leu --Arg--Pro--DA -la1--NH
(44)NH C-O-D Na -D Cp-a-D Ph-e Se-r Ap-h(-DMe)-D Mo-p Le- u Ar-g-Pro -AlaI-l' (44) NH C-O-D Na -D Cp-a-D Ph-e Se-r Ap-h(-DMe)-D Mo-p Le- u Ar-g-Pro -AlaI-l'
0 0
D NH  D NH
(45)NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg -Pro-D-AlaI0-NH  (45) NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-Arg-Pro-D-AlaI0-NH
(46)NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg - 9 (46) NTA-D-Nal1-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-Arg - 9
Pro-D-Ala10-NH  Pro-D-Ala10-NH
(47)NTA D NarD Cpa D Phe Ser Uph D Mop Leu Arg Pro D Ala1 NH (47)NTA D NarD Cpa D Phe Ser Uph D Mop Leu Arg Pro D Ala1 NH
(48)NTA--D--Nal1--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Leu - -Arg--Pro--D--Ala1--NH  (48) NTA--D--Nal1--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Leu--Arg--Pro--D- -Ala1--NH
(49)NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Leu-Arg-Pro-D-Ala1-NH  (49) NTA-D-Nar-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Leu-Arg-Pro-D-Ala1-NH
(50)NTA D Na1' D Cpa' D Phe' Ser' Phe(NOM) D Mop Leu A 9 (50)NTA D Na1' D Cpa' D Phe' Ser' Phe(NOM) D Mop Leu A 9
rg Pro D Ala10 Rg Pro D Ala10
NH  NH
(51)NTA-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph(Ac)-D-Mop-Leu- -- -- -- - - -- - - Arg--Pro--D--A 0(51)NTA-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph(Ac)-D-Mop-Leu- -- -- -- - -- -- - - Arg--Pro--D--A 0
la1--NH  la1--NH
(52)NTA-D-Nar-D-Cpa-D-Phe-Ser-Aph(-DM-e) D-Mop-Leu 9 (52) NTA-D-Nar-D-Cpa-D-Phe-Ser-Aph(-DM-e) D-Mop-Leu 9
-Arg-P-ro D-Ala10-Arg-P-ro D-Ala10
NH NH
6  6
(53)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-A 8 rg -Pro-D-Ala10-NH (53)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe-D-Mop-Leu-A 8 rg -Pro-D-Ala10-NH
6  6
(54)NDN-D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-A 8 rg -Pro-D-Ala10-NH  (54)NDN-D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Mop-Leu-A 8 rg -Pro-D-Ala10-NH
(55)NDN D NarD Cpa D Phe Ser Uph D M 6 (55)NDN D NarD Cpa D Phe Ser Uph D M 6
op Leu Arg Pro D Ala10 NH Op Leu Arg Pro D Ala10 NH
(56)NDN--D--Na1'--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Leu - -Arg--Pro--D--Ala10--NH  (56)NDN--D--Na1'--D--Cpa--D--Phe--Ser--Phe(NAM)--D--Mop--Leu - -Arg--Pro--D --Ala10--NH
( 6 57)NDN-D-Nal'-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Leu-Arg-Pro-D-Ala10 ( 6 57)NDN-D-Nal'-D-Cpa-D-Phe-Ser-Phe(NNM)-D-Mop-Leu-Arg-Pro-D-Ala10
-NH  -NH
(58)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-Leu- Arg-Pro-9 (58)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe(NOM)--D Mop-Leu- Arg-Pro-9
-D Ala-10 -D Ala-10
NH  NH
(59)NDN-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph(Ac) -D M-op -Leu - Arg -Pro -D-Ala10-NH  (59)NDN-D-Na1'-D-Cpa'-D-Phe'-Ser'-Aph(Ac) -D M-op -Leu - Arg -Pro -D-Ala10-NH
(60)NDN D NarD Cpa D Phe Ser Aph(DMe) D Mop Leu Arg Pro D Ala10 (60)NDN D NarD Cpa D Phe Ser Aph(DMe) D Mop Leu Arg Pro D Ala10
NH NH
(61)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe6 (61)Ac--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe6
--Leu--Arg-- Pro--D--Ala10--NH  --Leu--Arg-- Pro--D--Ala10--NH
(62)A 6 (62) A 6
c-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg- Pro-D-Ala10 c-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg- Pro-D-Ala10
-NH  -NH
(63)Ac D Na1! D Cpa D Phe Ser Mop D Uph Leu ArgPro D Ala10 (63)Ac D Na1! D Cpa D Phe Ser Mop D Uph Leu ArgPro D Ala10
NH  NH
(64)Ac-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu- 3 "8 -- -- -- - - -- - - Arg--Pro--D--Ala10(64)Ac-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu- 3 "8 -- -- -- - -- -- - - Arg--Pro--D--Ala10
--NH  --NH
(65)Ac-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6 (65)Ac-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6
-Leu- A 9 -Leu- A 9
rg-Pro-D-Ala10 rg-Pro-D-Ala10
-NH  -NH
(66)Ac-D-Nal'-D-Cpa-D-Phe-Ser'-Mop-D-Phe(NOM)6 (66)Ac-D-Nal'-D-Cpa-D-Phe-Ser'-Mop-D-Phe(NOM)6
-Leu- s Arg-Pro--D Ala-10 -Leu- s Arg-Pro--D Ala-10
NH  NH
(67)Ac-D-Na1-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac) A r - 9 -Leu - g Pro -D-Ala10 (67)Ac-D-Na1-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac) A r - 9 -Leu - g Pro -D-Ala10
-NH  -NH
(68)Ac D NarD Cpa D Phe Ser' Mop D Aph(DMe) Leu Arg Pro D Ala10 (68)Ac D NarD Cpa D Phe Ser' Mop D Aph (DMe) Leu Arg Pro D Ala10
NH NH
0 (69)D--Nal'--D--Cpa--D--Phe--Ser--Mop--D--Phe6--Leu--Arg--Pro9 - -D--Alal--NH 0 (69)D--Nal'--D--Cpa--D--Phe--Ser--Mop--D--Phe6--Leu--Arg--Pro9 - -D--Alal-- NH
(70)D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg-Pro -D-Alal-NH  (70) D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Arg-Pro-D-Alal-NH
(71)D-Nar 9 (71)D-Nar 9
-D-Cpa-D-Phe-Ser-Mop-D-Uph Leu-Arg-Pro -D Al-al-NH - -D-Cpa-D-Phe-Ser-Mop-D-Uph Leu-Arg-Pro -D Al-al-NH -
(72)D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg -Pro-D-Ala10-NH (72) D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg-Pro-D-Ala10-NH
(73)D Nal' D Cpa D Phe Ser Mop D Phe(NNM)6 (73)D Nal' D Cpa D Phe Ser Mop D Phe(NNM)6
Leu Arg Pro D Ala10 Leu Arg Pro D Ala10
NH NH
(74)D--Nar-D-Cpa-D-Phe--Ser--Mop--D--Phe(NOM)6 (74) D--Nar-D-Cpa-D-Phe--Ser--Mop--D--Phe(NOM)6
--Leu--Arg --Pro--D--Ala1 -- -- --NH  --Leu--Arg --Pro--D--Ala1 -- -- --NH
(75)D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac) -Leu -Arg -Pro-D-Ala10 (75) D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac) -Leu -Arg -Pro-D-Ala10
-NH  -NH
(76)D Nal' D Cpa' D Phe' Ser'Mop'D Aph(DMe) Leu Arg Pro D Ala10 (76)D Nal' D Cpa' D Phe' Ser'Mop'D Aph(DMe) Leu Arg Pro D Ala10
NH  NH
(77)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Ar -- -- -- - - -- - - g--Pro--D--Ala10--NH (77) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Ar -- -- -- - -- -- - - g--Pro--D--Ala10--NH
(78)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Ar g- 9 (78) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-Ar g- 9
Pro-D-Ala10 Pro-D-Ala10
?-NH  ?-NH
(79)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph Leu-Arg- 9 (79) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph Leu-Arg- 9
Pro-D Al-a'-NH - Pro-D Al-a'-NH -
(80)NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)6-Le u-Arg-Pro-D-Ala10-NH (80) NH CO-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)6-Le u-Arg-Pro-D-Ala10-NH
(81)NH CO D Na Cpa D Phe Ser Mop D Phe(NNM) Le (81) NH CO D Na Cpa D Phe Ser Mop D Phe(NNM) Le
9 rD  9 rD
u Arg Pro D Ala10u Arg Pro D Ala10
NH NH
(82) 6 NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)--Le u--Arg--Pro---D-Ala-10-NH  (82) 6 NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(NOM)--Le u--Arg--Pro- --D-Ala-10-NH
(83)NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)6 (83) NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)6
-Leu -Arg -Pro -D-Ala10-NH  -Leu -Arg -Pro -D-Ala10-NH
(84)NH C-O-D Na D Cp-a-D Ph-e Se-r' Mo (84) NH C-O-D Na D Cp-a-D Ph-e Se-r' Mo
-- - 0-r- -p-D Ap-h(DMe-) Le -u A 9 -- - 0-r- -p-D Ap-h(DMe-) Le -u A 9
rg Pro D Ala1 NH  Rg Pro D Ala1 NH
(85)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Arg -Pro-D-Ala10-NH  (85)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Arg-Pro-D-Ala10-NH
(86)NTA D NarD Cpa D Phe Ser' Mop D Aph Leu Arg 9 (86)NTA D NarD Cpa D Phe Ser' Mop D Aph Leu Arg 9
Pro D Ala10 Pro D Ala10
NH NH
(87)NTA--D--Nar--D--Cpa--D--Phe--Ser'--Mop--D--Uph-Leu--Arg - -Pro--D-Al-a1-0-NH - (87)NTA--D--Nar--D--Cpa--D--Phe--Ser'--Mop--D--Uph-Leu--Arg--Pro--D-Al-a1 -0-NH -
(88)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg- 9(88) NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NAM)-Leu-Arg- 9
Pro-D-Ala10-NH  Pro-D-Ala10-NH
(89)NTA D NarD Cpa D Phe Ser Mop D Phe(NNM)6 (89)NTA D NarD Cpa D Phe Ser Mop D Phe(NNM)6
Leu Arg Pro D Ala10 Leu Arg Pro D Ala10
NH  NH
(90)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Leu -- -- -- - - -- - - -Arg-8-Pro--D--Ala-10-NH (90)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Leu -- -- -- - - -- - - -Arg-8-Pro--D--Ala-10-NH
(91)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)6 (91)NTA-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph(Ac)6
-Leu- Arg -Pro -D-Ala10-NH  -Leu- Arg -Pro -D-Ala10-NH
(92)NTA-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(-DMe)-Leu -Arg-P-ro D-Ala10 NH (92)NTA-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Aph(-DMe)-Leu-Arg-P-ro D-Ala10 NH
8 8
(93)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Arg -Pro-D-Ala10-NH (93)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe-Leu-Arg-Pro-D-Ala10-NH
(94)NDN D Nal1 D Cpa D Phe Ser Mop D Aph Leu Arg Pro D Ala10 (94)NDN D Nal1 D Cpa D Phe Ser Mop D Aph Leu Arg Pro D Ala10
NH NH
(95)NDN--D--Nar--D--Cpa--D--Phe--Ser'--Mop--D--Uph-Leu--Arg - -Pro--D-Al-a!-0-NH - (95)NDN--D--Nar--D--Cpa--D--Phe--Ser'--Mop--D--Uph-Leu--Arg--Pro--D-Al-a !-0-NH -
(96)NDN-D-Nal1-D-Cpa-D-Phe-Ser'-Mop-D-Phe(NAM)-Leu-Arg-Pro-D-Ala1-NH (96)NDN-D-Nal1-D-Cpa-D-Phe-Ser'-Mop-D-Phe(NAM)-Leu-Arg-Pro-D-Ala1-NH
(97)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Leu -Arg-Pro-D-Ala1-NH  (97)NDN-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)-Leu-Arg-Pro-D-Ala1-NH
(98)NDN-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)6 (98)NDN-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)6
-Leu- Arg-Pro--D Ala-10 -Leu- Arg-Pro--D Ala-10
NH  NH
(99)NDN D NarD Cpa D Phe Ser Mop D Aph(Ac)6 (99)NDN D NarD Cpa D Phe Ser Mop D Aph(Ac)6
Leu Arg Pro D Ala10 Leu Arg Pro D Ala10
NH NH
(100)ND-N--D-Nal-'--D-Cpa'--D-Phe-'-Ser-'-Mop-'--D-Aph(DMe)-6-Le - u-Ar-g--Pro--D-Ala10-NH  (100) ND-N--D-Nal-'--D-Cpa'--D-Phe-'-Ser-'-Mop-'--D-Aph(DMe)-6-Le-u-Ar -g--Pro--D-Ala10-NH
(lODAc-D-Nar-D-Cpa-D-Phe'-Ser'-Leu'-D-Mop-Leu'-Arg-Pro-D-Ala10 (lODAc-D-Nar-D-Cpa-D-Phe'-Ser'-Leu'-D-Mop-Leu'-Arg-Pro-D-Ala10
-NH  -NH
(102)Ac D Nal' D Cpa D Phe Ser Tyr D Mop Leu Arg Pro D Ala10 (102)Ac D Nal' D Cpa D Phe Ser Tyr D Mop Leu Arg Pro D Ala10
NH  NH
(103)Ac-D-Nar-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-Arg -- -- -- - - -- - - - 9 (103)Ac-D-Nar-D-Cpa-D-Phe-Ser-Lys-D-Mop-Leu-Arg -- -- -- - - -- - - - 9
-Pro--D--Ala10--NH -Pro--D--Ala10--NH
(104)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Glu-D-Mop-Leu-Arg-Pro-D-Ala1-NH  (104)Ac-D-Nal1-D-Cpa-D-Phe-Ser-Glu-D-Mop-Leu-Arg-Pro-D-Ala1-NH
(105)Ac-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop-Leu-Arg -Pro-D-Ala1-NH  (105)Ac-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop-Leu-Arg-Pro-D-Ala1-NH
(106)A-c D N-al-' D C-pa-D P-he S-er A-rg-D M-op L-eu A 8 (106) A-c D N-al-' D C-pa-D P-he S-er A-rg-D M-op L-eu A 8
-rg P-ro-9 D A-la10 -rg P-ro-9 D A-la10
NH  NH
(107)D NarD Cpa D Phe Ser Leu D Mop Leu Arg Pr o D Ala10 NH (107)D NarD Cpa D Phe Ser Leu D Mop Leu Arg Pr o D Ala10 NH
(108)D--Nar--D--Cpa--D--Phe--Ser--Tyr--D--Mop--Leu--Arg--Pr o--D--Ala10--NH  (108) D--Nar--D--Cpa--D--Phe--Ser--Tyr--D--Mop--Leu--Arg--Pr o--D--Ala10--NH
(109)D NarD Cpa D Phe Ser (109)D NarD Cpa D Phe Ser
0 - -- -- - -Lys-D-Mop-Leu-Arg-Pr o-D-Ala1-NH  0 - -- -- - -Lys-D-Mop-Leu-Arg-Pr o-D-Ala1-NH
(110)D-Nar-D-Cpa-D-Phe-Ser-G1u-D-Mop-Leu'-Arg-Pro-D-Ala1-NH  (110)D-Nar-D-Cpa-D-Phe-Ser-G1u-D-Mop-Leu'-Arg-Pro-D-Ala1-NH
( 8 111)D-Na1!-D-Cpa-D-Phe-Ser-G 6 ( 8 111)D-Na1!-D-Cpa-D-Phe-Ser-G 6
In-D-Mop-Leu-Arg-Pr o-D-Ala1-NH  In-D-Mop-Leu-Arg-Pr o-D-Ala1-NH
(112)D Nal' D Cpa' D Phe' Ser' Arg' D Mop'Leu' Arg' Pr 9  (112)D Nal' D Cpa' D Phe' Ser' Arg' D Mop'Leu' Arg' Pr 9
o D Ala10 NHo D Ala10 NH
(113)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Leu--D--Mop--Leu--A rg--Pro--D--Ala10--NH  (113) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Leu--D--Mop--Leu--A rg--Pro--D-- Ala10--NH
(114)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mop-Leu-A rg-Pro-D-Ala1-NH  (114) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Tyr-D-Mop-Leu-A rg-Pro-D-Ala1-NH
(115)NH CO D Nal' D Cpa D Phe Ser Lys D 6 (115)NH CO D Nal' D Cpa D Phe Ser Lys D 6
Mop Leu Arg Pro D Ala1 NH  Mop Leu Arg Pro D Ala1 NH
(116)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Glu-D-Mop6-Leu-A - -- -- - - -- - - rg--Pro--D--Ala1-0--NH (116) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Glu-D-Mop6-Leu-A - -- -- - - -- - - rg--Pro--D--Ala1-0--NH
(117)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop-Leu-A 9  (117) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop-Leu-A 9
rg-P -D-A 1rg-P -D-A 1
ro la-NH Ro la-NH
6  6
(118)N-H CO-D-Na1'-D-Cpa -D Phe-Ser Arg-D-Mop-Leu-Arg-Pro-9-D Ala-10 (118) N-H CO-D-Na1'-D-Cpa -D Phe-Ser Arg-D-Mop-Leu-Arg-Pro-9-D Ala-10
NH  NH
(119)D N-a1-' D C-pa-'D P-he-' Ser-' Phe-(NNM) D Mo-p-Leu-Ar g - 9 (119)D N-a1-' D C-pa-'D P-he-' Ser-' Phe-(NNM) D Mo-p-Leu-Ar g - 9
Pro -D Ala-10-NH - Pro -D Ala-10-NH -
(120)NTA D Na1' D Cpa' D Phe'Ser' Phe(COOH) D Mop L(120)NTA D Na1' D Cpa' D Phe'Ser' Phe(COOH) D Mop L
9  9
eu A 8Eu A 8
rg Pro D Ala10 Rg Pro D Ala10
NH NH
(121)NTA--D--Nar--D--Cpa--D--Phe--Ser--Phe(-CA-M)-D-Mop--Le u--Arg--Pro--D--Ala10--NH  (121) NTA--D--Nar--D--Cpa--D--Phe--Ser--Phe(-CA-M)-D-Mop--Le u--Arg--Pro-- D--Ala10--NH
( ] ( ]
122)NTA-D-Na1-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10 122) NTA-D-Na1-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10
NH  NH
(123)NTA-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop' D Phe-(C-AM)6 (123)NTA-D-Na1'-D-Cpa'-D-Phe'-Ser'-Mop' D Phe-(C-AM)6
-Leu -Arg -Pro -D-Ala1 -NH  -Leu -Arg -Pro -D-Ala1 -NH
(124)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-L eu-Arg-Pro--D Ala-10 (124)NDN-D-Nar-D-Cpa-D-Phe-Ser-Phe(COOH)--D Mop-L eu-Arg-Pro--D Ala-10
NH  NH
(125)NDN D Nal1 D Cpa D Phe Ser Phe(CAM) D Mop Le u A 8 (125)NDN D Nal1 D Cpa D Phe Ser Phe(CAM) D Mop Le u A 8
rg Pro D AlaI0 Rg Pro D AlaI0
NH NH
(126)NDN--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(COOH)--L eu--Arg--Pro-9--D-Ala-10-NH  (126)NDN--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Phe(COOH)--L eu--Arg--Pro-9- -D-Ala-10-NH
(127)NDN (127)NDN
9 -D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10 9 -D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-Le u-Arg-Pro-D-Ala10
-NH  -NH
(128)CAM D Nal1 D Cpa D Phe Ser Mop D Phe(NAM) Le (128)CAM D Nal1 D Cpa D Phe Ser Mop D Phe(NAM) Le
9 9
u Arg Pro D Ala10 NH u Arg Pro D Ala10 NH
(129)CAM-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6-Le 9 -- -- -- - - -- - U--Arg--Pro--D--Ala10--NH (129) CAM-D-Nal1-D-Cpa-D-Phe-Ser-Mop-D-Phe(NNM)6-Le 9 -- -- -- - - -- - U--Arg--Pro--D--Ala10--NH
(130)CAM-D-Na1! D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Le u-Arg-Pro-D-Ala10- -NH  (130) CAM-D-Na1! D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Le u-Arg-Pro-D-Ala10- -NH
(131)CAM-D-Nal' (131) CAM-D-Nal'
Arg -Pro -D-A I0-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM) -Le s u - la -NH  Arg -Pro -D-A I0-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM) -Le s u - la -NH
(132)CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10 (132) CAM-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Phe(COOH)-L eu-Arg-Pro--D Ala-10
NH  NH
(133)CEC D Nal1 D Cpa D Phe Ser Mop D Phe(NAM)6 (133)CEC D Nal1 D Cpa D Phe Ser Mop D Phe(NAM)6
Le u Arg Pro D Ala10 Le u Arg Pro D Ala10
NH NH
0 (134)CEC--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Phe(NNM)6--Le u--A 90 (134)CEC--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Phe(NNM)6--Le u--A 9
rg--Pro--D--Ala10--NH  rg--Pro--D--Ala10--NH
(135)CEC (135) CEC
8 -D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Le u-Arg-Pro-D-Ala10-NH  8-D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Phe(NOM)-Le u-Arg-Pro-D-Ala10-NH
(136)CEC-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Phe(CAM) -Les u -Arg - 9 (136)CEC-D-Nal'-D-Cpa'-D-Phe'-Ser'-Mop'-D-Phe(CAM) -Les u -Arg - 9
Pro -D-Ala10-NH  Pro -D-Ala10-NH
(137)CEC-D-Nal' D Cpa' D Phe' Ser' Mop' D Ph-e(-COOH)-L -A 0-- -- - - eu rg-Pro--D Ala-1 NH  (137)CEC-D-Nal' D Cpa' D Phe' Ser' Mop' D Ph-e(-COOH)-L -A 0-- -- - - eu rg-Pro--D Ala-1 NH
(138)CAM D Na1! D Cpa D Phe Ser' Phe(NAM) D Mop Le u Arg Pro D Ala10 (138)CAM D Na1! D Cpa D Phe Ser' Phe(NAM) D Mop Le u Arg Pro D Ala10
NH NH
(139)CAM--D--Nar--D--Cpa--D--Phe--Ser--Phe(NNM)--D--Mo 6 p--Le u--Arg--Pro--D--Ala10--NH  (139)CAM--D--Nar--D--Cpa--D--Phe--Ser--Phe(NNM)--D--Mo 6 p--Le u--Arg--Pro- -D--Ala10--NH
(140)CAM-D-Na1'-D-Cpa'-D-Phe'-Ser'-Phe(NOM)-D-Mop (140) CAM-D-Na1'-D-Cpa'-D-Phe'-Ser'-Phe(NOM)-D-Mop
9 -Le u-Arg-Pro-D-Ala1-NH  9 -Le u-Arg-Pro-D-Ala1-NH
(141)CAM D NarD Cpa D Phe Ser Phe(CAM) D Mop Le u Arg Pro D Ala10 (141) CAM D NarD Cpa D Phe Ser Phe (CAM) D Mop Le u Arg Pro D Ala10
NH  NH
(142)CAM-D-Nal'-D-Cpa'-D-Phe'-Ser'-Phe(COOH)-D-Mop-L -- -- -- - - -- - eu--Arg--Pro-9--D-Ala-10-NH (142) CAM-D-Nal'-D-Cpa'-D-Phe'-Ser'-Phe(COOH)-D-Mop-L -- -- -- - -- -- - eu--Arg--Pro-9--D-Ala-10-NH
(143)CEC-D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Le -A 9  (143) CEC-D-Nar-D-Cpa-D-Phe-Ser-Phe(NAM)-D-Mop-Le-A 9
u rg-Pro-D-Ala10-NH u rg-Pro-D-Ala10-NH
(144)CEC-D-Nal1-D-Cpa-D-Phe-Ser-Phe(NNM)-D (144) CEC-D-Nal1-D-Cpa-D-Phe-Ser-Phe(NNM)-D
9 -Mop-Leu-Arg-Pro-D-Ala10-NH  9 -Mop-Leu-Arg-Pro-D-Ala10-NH
(145)CEC-D-NarD-Cpa-D-Phe-Ser-Phe(NOM)-D-Mop-Le u-Arg-Pro-D-Ala10- -NH  (145) CEC-D-NarD-Cpa-D-Phe-Ser-Phe(NOM)-D-Mop-Le u-Arg-Pro-D-Ala10- -NH
(146)CEC D NarD Cpa D Phe Ser Phe(CAM) D M 6 op Le u Arg Pro D Ala10 (146) CEC D NarD Cpa D Phe Ser Phe (CAM) D M 6 op Le u Arg Pro D Ala10
NH NH
(147)CEC-D--N-ar-D--C-pa-D--P-he-S-er-P-he(C-OO-H)-D--Mop--L eu--Arg--P-ro-D--Ala10-NH  (147) CEC-D--N-ar-D--C-pa-D--P-he-S-er-P-he(C-OO-H)-D--Mop--L eu- -Arg--P-ro-D--Ala10-NH
(148)NH CO D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Aph-Leu-A 9 - rg-Pro-D-Ala10 (148) NH CO D-Nar-D-Cpa-D-Phe-Ser-Aph-D-Aph-Leu-A 9 - rg-Pro-D-Ala10
-NH  -NH
(149)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-A 6 (149) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-A 6
ph Leu-Arg-Pro-D-Ala10 Ph Leu-Arg-Pro-D-Ala10
-NH  -NH
(150)NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Uph'-D-Aph-Leu'-A rg-Pro-D-Ala1-NH  (150) NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Uph'-D-Aph-Leu'-A rg-Pro-D-Ala1-NH
( 6 (6
151)NH CO D NarD Cpa D Phe Ser Aph D Uph Leu A rg Pro D Ala10 151) NH CO D NarD Cpa D Phe Ser Aph D Uph Leu A rg Pro D Ala10
NH NH
(152)NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Gln--D--Uph--Leu--A rg--Pro--D--Ala10--NH  (152) NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Gln--D--Uph--Leu--A rg--Pro--D-- Ala10--NH
(153)NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Uph' D U-ph-'Leu-' A rg-Pro-D A-la-10 (153) NH CO-D-Na1'-D-Cpa'-D-Phe'-Ser'-Uph' D U-ph-'Leu-' A rg-Pro-D A-la-10
NH- NH-
(154)NH CO D Na pa D Phe Se D Uph Le(154) NH CO D Na pa D Phe Se D Uph Le
0rD C r Aph(Ac) 6 u Arg P 9 0rD C r Aph(Ac) 6 u Arg P 9
ro D Ala1 NH  Ro D Ala1 NH
(155)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Aph(Ac )-Leu-Arg-P 9(155) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Aph(Ac )-Leu-Arg-P 9
ro-D-Ala10-NH  ro-D-Ala10-NH
(156)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Aph(Ac)-Le (156) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Aph(Ac)-Le
9  9
u-Arg-Pro-D-Ala10-NH u-Arg-Pro-D-Ala10-NH
(157)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Uph-D-Aph(Ac)-Le (157) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Uph-D-Aph(Ac)-Le
9 9
u-Arg-Pro-D-Ala10-NH u-Arg-Pro-D-Ala10-NH
(158)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-C it--Pro--D-A-la-10-NH- (159)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(-Ac)--Le u Cit Pro D Ala10 (158) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-C it--Pro--DA-la-10-NH- (159)NH CO-- D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(-Ac)--Le u Cit Pro D Ala10
NH NH
6 6
(160)NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu I (160)NH CO D Nal' D Cpa D Phe Ser Mop D Aph Leu I
Iys-Pro-D-Ala10-NH Iys-Pro-D-Ala10-NH
(161)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-I orn-Pro-D-Ala1-NH  (161) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-I orn-Pro-D-Ala1-NH
(162)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-A rg-Pro-D-Ala10-NH  (162) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-A rg-Pro-D-Ala10-NH
(163)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Pro-D-M 6 (163) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Pro-D-M 6
op-Leu-A rg-Pro-D-Ala10-NH  op-Leu-A rg-Pro-D-Ala10-NH
(164)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-G In-Pro-D-Ala10-NH (164) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-G In-Pro-D-Ala10-NH
(165)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph6-Leu-L ys(Bzl)-Pro-D-Ala10-NH  (165) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph6-Leu-L ys(Bzl)-Pro-D-Ala10-NH
(166)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-A 6 (166) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-A 6
ph-Leu-A sp-Pro-D-Ala10-NH  ph-Leu-A sp-Pro-D-Ala10-NH
(167)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Asn-Leu-A 9 (167) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Asn-Leu-A 9
rg-Pro-D-Ala10-NH rg-Pro-D-Ala10-NH
(168)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Gl 6 (168) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Gl 6
u-Leu-A -- -- -- - - -- - - rg--Pro--D--Ala10--NHu-Leu-A -- -- -- - - -- - - rg--Pro--D--Ala10--NH
6  6
(169)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-G Iu-Pro-D-Ala1-NH  (169) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Aph-Leu-G Iu-Pro-D-Ala1-NH
(170)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph Leu-Asn-Pro-D A-la-10 (170) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph Leu-Asn-Pro-D A-la-10
NH NH
?- ?-
(171)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Amp(-Ac) -Le u -Arg -Pr-o D A-la' NH(171) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop-D-Amp(-Ac) -Le u -Arg -Pr-o D A-la' NH
6  6
(172)NH CO D NarD Cpa D Phe Ser Mop D Amp Leu A rg Pro D Ala10 (172) NH CO D NarD Cpa D Phe Ser Mop D Amp Leu A rg Pro D Ala10
NH NH
(173)NH CO--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Mop'-Leu--! Lys--Pro--D-Al-a1-0-NH - (173) NH CO--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Mop'-Leu--! Lys--Pro --D-Al-a1-0-NH -
(174)NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-L eu-Ily-s Pr-o-D Ala-10(174) NH CO-D-Na1'-D-Cpa-D-Phe-Ser-Mop-D-Phe(CAM)-L eu-Ily-s Pr-o-D Ala-10
NH  NH
(175)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aarp(-Ac) -Leu -Glu -Pr-o D A-la1 NH  (175) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aarp(-Ac) -Leu -Glu -Pr-o D A-la1 NH
(176)NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop D M 6 (176) NH CO-D-Nal'-D-Cpa-D-Phe-Ser-Mop D M 6
-op-Leu-G Iu P-ro D-Ala-10-NH - -op-Leu-G Iu P-ro D-Ala-10-NH -
(177)NH CO D NarD Cpa D Phe Ser Aph(Ac) D M 6 op (A c) Arg Pro D Ala10 (177) NH CO D NarD Cpa D Phe Ser Aph(Ac) D M 6 op (A c) Arg Pro D Ala10
c NHc NH
(178)NH CO--D--Na1!--D--Cpa--D--Phe--S 6 er--Aph(-Ac-)-D-Mop--(A cc)--Arg--P 9 (178) NH CO--D--Na1!--D--Cpa--D--Phe--S 6 er--Aph(-Ac-)-D-Mop--(A cc)--Arg --P 9
ro--D--Ala1--NH  ro--D--Ala1--NH
(179)NH CO D (179) NH CO D
8 --Na1'-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Ac)-(A cc)-Arg-Pro-D-Ala1-NH  8 --Na1'-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Ac)-(A cc)-Arg-Pro-D-Ala1-NH
(180)NH CO D Nal' D Cpa D Phe Ser' Mop D Aph(Ac) (Acc) Arg Pro D Ala1 NH  (180)NH CO D Nal' D Cpa D Phe Ser' Mop D Aph(Ac) (Acc) Arg Pro D Ala1 NH
(181)NTA-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-Arg --Pro--D--Ala10--NH (181)NTA-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Pro-Leu-Arg --Pro--D--Ala10--NH
(182)NTA (182) NTA
0-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop Leu-Arg-Pro-D A-la-1 NH- 0-D-Nar-D-Cpa-D-Phe-Ser-Gln-D-Mop Leu-Arg-Pro-D A-la-1 NH-
U83)NTA-D-Nar-D-Cpa-D-Phe-Ser-Gln D A-ph-(Ac)-Leu Ar-g Pr-o D-Al-a1 NH-U83)NTA-D-Nar-D-Cpa-D-Phe-Ser-Gln D A-ph-(Ac)-Leu Ar-g Pr-o D-Al-a1 NH-
(184)NTA-D-Nar-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Mop-(Ac c )-Arg-Pro-D-Ala10-NH (184) NTA-D-Nar-D-Cpa-D-Phe-Ser-Aph(Ac)-D-Mop-(Ac c )-Arg-Pro-D-Ala10-NH
(185)NTA D NarD Cpa D Phe Ser Aph(Ac) D Mop (Ac 6  (185) NTA D NarD Cpa D Phe Ser Aph(Ac) D Mop (Ac 6
c) Arg Pro D Ala10c) Arg Pro D Ala10
NH NH
(186)NTA--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Aph(Ac)--(Ac (186) NTA--D--Na1'--D--Cpa'--D--Phe'--Ser'--Mop'--D--Aph(Ac)--(Ac
9  9
c)--Arg--Pro--D--Ala10--NH c)--Arg--Pro--D--Ala10--NH
(187)NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(-Ac) -(Ac c-) A-rg- 9 (187) NTA-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(-Ac) -(Ac c-) A-rg- 9
Pro-D AlaI0 Pro-D AlaI0
NH  NH
(188)NTA-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-A 6 (188) NTA-D-Na1!-D-Cpa-D-Phe-Ser-Mop-D-A 6
sn-Leu-Arg -Pro-D-Ala10-NH  sn-Leu-Arg -Pro-D-Ala10-NH
(189)NTA rg - 9 (189)NTA rg - 9
Pro-D-Ala1-D-Na1'-D-Cpa-D-Phe-Ser'-Mop-D-Glu-Leu-A Pro-D-Ala1-D-Na1'-D-Cpa-D-Phe-Ser'-Mop-D-Glu-Leu-A
-NH  -NH
(190)NTA D Nal' D Cpa' D Phe'Ser' Aph' D Mop' Leu' Arg 9 (190)NTA D Nal' D Cpa' D Phe'Ser' Aph' D Mop' Leu' Arg 9
Pro D Ala10 Pro D Ala10
NH NH
(191)NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Aph(Enanth yl-)6-Le-u-Ar-g-Pr-9 (191) NH CO--D--Nal1--D--Cpa--D--Phe--Ser--Mop--D--Aph(Enanth yl-)6-Le-u-Ar-g- Pr-9
o--D-Ala-10-NH  o--D-Ala-10-NH
(192)NH CO-D-Nal1-D -D-Phe-Ser-Mop-D Aph(Lauryl ) A 9 - L-eu -rg P-ro D-A- 0 (192) NH CO-D-Nal1-D -D-Phe-Ser-Mop-D Aph(Lauryl ) A 9 - L-eu -rg P-ro D-A- 0
la1-Cpa la1-Cpa
N-H  N-H
(193)NH CO D NarD Cpa D Phe Ser Mop D Aph(Palmityl)6 (193)NH CO D NarD Cpa D Phe Ser Mop D Aph(Palmityl)6
Leu A 8 Leu A 8
rg Pro D Ala10 Rg Pro D Ala10
NH  NH
(194)NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Butyry -- -- -- - - -- 1)-Le-u-Ar-g-Pr-o-D--Al-a10-NH-(194) NH CO-D-Nar-D-Cpa-D-Phe-Ser'-Mop-D-Aph(Butyry -- -- -- -- -- -- 1)-Le-u-Ar-g-Pr-oD--Al-a10-NH-
(195)NH CO-D-Nal1(195) NH CO-D-Nal1
9-D-Cpa-D-Phe-Ser-Mop-D-Aph(Nicoti noyl)-Leu-Arg-Pro-D-Ala10 9-D-Cpa-D-Phe-Ser-Mop-D-Aph(Nicoti noyl)-Leu-Arg-Pro-D-Ala10
-NH  -NH
(196)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Pe-larg -onyl)-Leu-Arg--Pro D-A 0 (196) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Pe-larg-onyl)-Leu-Arg--Pro D-A 0
la1 NH  La1 NH
(197)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-E-t)6 Le-u Ar-g Pr-o D-Al-a1 NH- (197) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-E-t)6 Le-u Ar-g Pr-o D-Al-a1 NH-
(198)NH CO D Nal' D Cpa D Phe Ser Mop D Uph(Di n P r) Leu A 9(198) NH CO D Nal' D Cpa D Phe Ser Mop D Uph (Di n P r) Leu A 9
rg Pro D A 0 Rg Pro D A 0
la1 NH La1 NH
(199)NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(Piperi dyl-C-O)-L-eu-A-rg-P-ro-D--A-la10-N-H  (199) NH CO--D--Nar--D--Cpa--D--Phe--Ser--Mop--D--Aph(Piperi dyl-CO)-L-eu-A-rg- P-ro-D--A-la10-NH
(200)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Mo-rp o 1in-y1 CO-) L-eu A-rg- 9 -h (200) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(Mo-rp o 1in-y1 CO-) L-eu A-rg- 9 -h
Pro-D Ala10 Pro-D Ala10
NH  NH
(201)NH CO-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-i P -r) - - --9 (201) NH CO-D-Nal!-D-Cpa-D-Phe-Ser-Mop-D-Uph(Di-i P -r) - - --9
Leu Arg Pro D Al-a10 Leu Arg Pro D Al-a10
NH  NH
(202)NH CO D N-ar-D C-pa-D P-he-Ser-Mop-D U-ph-(Di Et) -Leu-Arg-Pro-D-AlaI0-NH  (202) NH CO D N-ar-D C-pa-D P-he-Ser-Mop-D U-ph-(Di Et) -Leu-Arg-Pro-D-AlaI0-NH
(203)Enanthyl D NarD Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala10 (203)Enanthyl D NarD Cpa D Phe Ser Mop D Aph(Ac) Leu Arg Pro D Ala10
NH NH
(204)Lauryl-D--N-al'-D--C-pa-D--P-he-S-er-M-op-D--A-ph(Ac)- L-eu-A-rg-P- 9 (204) Lauryl-D--N-al'-D--C-pa-D--P-he-S-er-M-op-D--A-ph(Ac)- L-eu-A -rg-P- 9
ro-D--A-la-N-H  ro-D--A-la-N-H
(205)Palmity-l-D Na (205) Palmity-l-D Na
0r--D Cpa--D Phe-Ser-Mop--D Aph(Ac)-Leu-Arg-Pro-D-Ala1-NH  0r--D Cpa--D Phe-Ser-Mop--D Aph(Ac)-Leu-Arg-Pro-D-Ala1-NH
(206)Butyryl D Na (206)Butyryl D Na
9 rD Cpa D Phe Ser Mop D Aph(Ac)6 Leu Arg Pro D Ala10 9 rD Cpa D Phe Ser Mop D Aph(Ac)6 Leu Arg Pro D Ala10
NH  NH
(207)Nicotinoyl-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph(A -- -- -- - - -- c)--Leu--Arg--Pro--D--Ala1--NH (207) Nicotinoyl-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Aph (A -- -- -- - -- -- c)--Leu--Arg--Pro--D--Ala1--NH
(208)Pe-lar-gony-l-D Nal-1 (208) Pe-lar-gony-l-D Nal-1
6 -D Cpa--D Phe-Ser-Mop--D Aph(A c)-Leu-Arg-Pro--D Ala-10 6 -D Cpa--D Phe-Ser-Mop--D Aph(A c)-Leu-Arg-Pro--D Ala-10
NH  NH
(209)Di-E-t N-CO D-N-al1 D-C-pa D-P-he S-er M-op D-A-ph(Ac)6 (209)Di-E-t N-CO D-N-al1 D-C-pa D-P-he S-er M-op D-A-ph(Ac)6
L-eu A-rg P-ro D-A-la10 N-H  L-eu A-rg P-ro D-A-la10 N-H
(210)Di n Pr N-CO-D-Nar-D-Cpa -D-Phe -Ser M-op -D-Aph( Ac) -Leu -Arg - 9 (210) Di n Pr N-CO-D-Nar-D-Cpa -D-Phe -Ser M-op -D-Aph( Ac) -Leu -Arg - 9
Pro -D-Ala10 Pro-D-Ala10
-NH  -NH
(211)Piperidyl CO D Na (211) Piperidyl CO D Na
6 rD Cpa D Phe Ser Mop D Aph (Ac) Leu Arg Pro D Ala1 NH 6 rD Cpa D Phe Ser Mop D Aph (Ac) Leu Arg Pro D Ala1 NH
(212)Mo-rp-hol-inyl--C-O-D-N-ar--D-C-pa--D-P-he-S-er'-M-op--D-A ph(A-c)-L-eu-A-rg-P-ro-9-D-A-la1-NH  (212) Mo-rp-hol-inyl--CODN-ar--DC-pa--DP-he-S-er'-M-op--DA ph(Ac)-L-eu-A-rg- P-ro-9-DA-la1-NH
(213)Di-i-Pr N-CO-D Na-l'-D Cp-a-D Ph-e Se-r' Mo-p-D Aph( Ac-) Le-u Ar-g Pr-o-D Al-a10 (213) Di-i-Pr N-CO-D Na-l'-D Cp-a-D Ph-e Se-r' Mo-p-D Aph( Ac-) Le-u Ar-g Pr-o-D Al-a10
NH  NH
(214)Di Et N-CO-D N-ar-D C-pa-D P-he S-er M-op- D Aph(A-c) -Leu -Arg-Pr-o D-Ala10 (214) Di Et N-CO-D N-ar-D C-pa-D P-he S-er M-op- D Aph(A-c) -Leu -Arg-Pr-o D-Ala10
NH  NH
(215)Ben-zo-y1 D-Na-1' D-Cp-a' D-Phe'-Ser-Mo-p D Aph(-Ac) -L eu -Arg -Pr-9 (215) Ben-zo-y1 D-Na-1' D-Cp-a' D-Phe'-Ser-Mo-p D Aph(-Ac) -L eu -Arg -Pr-9
o D A-la1 NH  o D A-la1 NH
(216)CHF D Nal' D Cpa'D Phe'Ser'Mop (216)CHF D Nal' D Cpa'D Phe'Ser'Mop
9 'D Aph(Ac)6 9 'D Aph(Ac)6
Leu Arg Pro D Ala1 NH Leu Arg Pro D Ala1 NH
(217)MOBA-D-Na1-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph(Ac)--Leu- -Arg--Pro-9 -- --D-Ala-10-NH  (217)MOBA-D-Na1-'--D-Cpa-'--D-Phe-'-Ser-'-Mop-'--D-Aph(Ac)--Leu--Arg--Pro- 9 -- --D-Ala-10-NH
(218)CPF D-N-a1' D-C-pa' D-P-he'S-er' M-op'D-A-ph(Ac)-L-eu Arg-Pro-D Al-a10 (218) CPF D-N-a1' D-C-pa' D-P-he'S-er' M-op'D-A-ph(Ac)-L-eu Arg-Pro-D Al-a10
N-H- - N-H- -
(219)NH CO D NarD Cpa D Phe Ser Mop D Uph(Di n Butyl) 9(219) NH CO D NarD Cpa D Phe Ser Mop D Uph (Di n Butyl) 9
Leu Arg Pro D AlaI0 Leu Arg Pro D AlaI0
NH  NH
(220)NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph(Propyl) Leu g o a (220) NH CO-D-Nar-D-Cpa-D-Phe-Ser-Mop-D-Uph(Propyl) Leu goa
( 1) n Buty a pa, he e op, p h( c) Leu g o a  (1) n Buty a pa, he e op, p h( c) Leu g o a
( ) uty y a pa he e op ph( u yy ) Leu g P o a  ( ) uty y a pa he e op ph( u yy ) Leu g P o a
( ) c a pa he, e op ph( e a gony ) Leu g o a  ( ) c a pa he, e op ph( e a gony ) Leu g o a
( ) c pa h , e op ph( u y y ) L eu g o a 和 ( ) c pa h , e op ph( u y y ) L eu g o a and
( ) a pa he, e op ph( enty 1)6 Leu g o a  ( ) a pa he, e op ph( enty 1)6 Leu g o a
自上面 出的化合物( ), ( ), ( ), ( ), ( ), ( ) ( ) ( 1), ( ), ( ), ( ), ( ), ( ), ( ), ( ), ( 1) ( ) ( ), ( ), ( ), ( ), ( 1), ( ), ( ) ( ), ( ) ( ), ( ), ( ), ( ), (1 ) (1 ), (1 ) (1 ), (11 , (11 , (11 ) (1 ) (1 , (1 , (1 1 (1 ), (1 ), (1 ), (1 1), (1 ), (1 )和(1 ).  Compounds from above ( ), ( ), ( ), ( ), ( ), ( ) ( ) ( 1), ( ), ( ), ( ), ( ), ( ), ( ), ( ), ( 1) ( ) ( ), ( ), ( ), ( ), ( 1), ( ), ( ) ( ), ( ) ( ), ( ), ( ), ( ), (1 ) (1 ), ( 1) (1), (11, (11, (11) (1) (1, (1, (1 1 (1), (1), (1), (1 1), (1), (1 )and 1 ).
. 各 要求 1的 ( ) 衍生物的方法,其中 (1) 十 衍生物的 各 固相合成方法, 方法以 B  . Each of the methods of claim 1 ( ), wherein (1) each of the ten derivatives is solid phase synthesis method, the method is B
休, Boc 策略, 到 未 方法包括以下步 驟 Hugh, Boc strategy, to no method includes the following steps
將 十位的保 的氨基酸原料以 / 或 /  Put the ten amino acid raw materials in / or /
合 B B
反 完全 /二氧 Boc 1 中和 下 介氨基酸原料 Anti-complete/dioxo Boc 1 Intermediate and lower amino acid raw materials
上 順序依次將十 氨基酸都 到 上  The top ten amino acids are in order
將最終所得到的 經 F裂解得到  The resulting F-cracking is obtained.
裂解完成 , 水 , 水 , 化 得到 。 . 物組合物 含有至少 要求 1 中任 項的 (1) 十 衍生物或 休 休或 生理毒性 和可 休或賦 形 。 . 要求 的 物組合物,其中 (1)十 衍生物或 休 休或 生理毒性 要求 中的 ( )d 衍 生物或 休 休或 生理毒性 。 . 要求 1 中任 項的 (1)十 衍生物或 休 休或 生理毒性 在 各 物中的用途, 物用于預防或 治行性激素相夫疾病 ( 性激素相夫癌症, *** 、 子宮 膜 、 乳腺 ) 或 于避孕 或 于拮抗L 、 拮抗 L 休、 抑制 休分泌 性腺激素(例 L 和/或F )和/或抑制性腺分泌 矣激素(例 ***、 激素和/或 ),或 于降低 釋放 、 反 。 . 預防或治行性激素相夫疾病 ( 性激素相夫癌症, *** 、 子宮 膜 、 乳腺 )或避孕的方法, 方法包括給予患者或 避孕者有效 量的 (1+ 衍生物或 休 休或 生理 毒性 。 . 拮抗 、 拮抗L 休、 抑制 休分泌 性腺激素(例 和/或 F )和/或抑制性腺分泌 矣激素(例 ***、 激 素和/或 )的方法, 方法包括給予需要者有效 量的 (1) 十 衍生物或 休 休或 生理毒性 。 1 . 降低 、 反 的方法 方法包括給 予需要者有效 量的 (1)十 衍生物或 休 休或 生 理毒性 。 The cracking is completed, water, water, and chemical. . The composition contains at least one of the derivatives (1) of claim 1 or resting or physiologically toxic and reclusive or shaped. . The claimed composition, wherein (1) a ten derivative or a (d) derivative in resting or physiological toxicity requirements or rest or physiological toxicity. . The use of (1) ten derivatives or rest or physiological toxicity in claim 1 for the prevention or treatment of sex hormones (sex hormones, prostate, uterine membrane, mammary gland) or In contraception or in antagonizing L, antagonizing L, taking off hormones (such as L and / or F) and / or inhibiting gonadotropin secretion (such as estrogen, hormones and / or), or in reducing release, anti-. . A method of preventing or treating a sexual hormone-related disease (sex hormone, cancer, prostate, uterine membrane, breast) or contraception, the method comprising administering to the patient or the contraceptive an effective amount (1+ derivative or resting or physiological toxicity). . A method of antagonizing, antagonizing, or inhibiting gonadotropin (such as and/or F) and/or inhibiting gonadotropin secretion (such as estrogen, hormone, and/or), the method comprising administering an effective amount to a person in need thereof (1) Ten derivatives or rest or physiological toxicity. 1 . A reduced, reverse method comprises administering an effective amount of (1) a ten derivative or resting or physiological toxicity to a subject in need thereof.
PCT/CN2009/000648 2009-06-11 2009-06-11 Lhrh antagonist with long potency and low histamine releasing effect WO2010142060A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2009/000648 WO2010142060A1 (en) 2009-06-11 2009-06-11 Lhrh antagonist with long potency and low histamine releasing effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2009/000648 WO2010142060A1 (en) 2009-06-11 2009-06-11 Lhrh antagonist with long potency and low histamine releasing effect

Publications (1)

Publication Number Publication Date
WO2010142060A1 true WO2010142060A1 (en) 2010-12-16

Family

ID=43308359

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2009/000648 WO2010142060A1 (en) 2009-06-11 2009-06-11 Lhrh antagonist with long potency and low histamine releasing effect

Country Status (1)

Country Link
WO (1) WO2010142060A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
CN1443195A (en) * 2000-03-14 2003-09-17 赞塔里斯股份公司 LHRH-antagonists, production and use thereof as medicament
CN1781935A (en) * 2004-12-01 2006-06-07 中国人民解放军军事医学科学院毒物药物研究所 Novel LHRH antagonist
CN101037472A (en) * 2006-03-14 2007-09-19 中国人民解放军军事医学科学院毒物药物研究所 LHRH antagonist with low-histamine releasing function
CN101597321A (en) * 2008-06-03 2009-12-09 中国人民解放军军事医学科学院毒物药物研究所 The lhrh antagonist of long-acting low-histamine release side effect

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
CN1443195A (en) * 2000-03-14 2003-09-17 赞塔里斯股份公司 LHRH-antagonists, production and use thereof as medicament
CN1781935A (en) * 2004-12-01 2006-06-07 中国人民解放军军事医学科学院毒物药物研究所 Novel LHRH antagonist
CN101037472A (en) * 2006-03-14 2007-09-19 中国人民解放军军事医学科学院毒物药物研究所 LHRH antagonist with low-histamine releasing function
CN101597321A (en) * 2008-06-03 2009-12-09 中国人民解放军军事医学科学院毒物药物研究所 The lhrh antagonist of long-acting low-histamine release side effect

Similar Documents

Publication Publication Date Title
US5843446A (en) Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
CN1847261B (en) Cyclic peptides as g-protein-coupled receptor antagonists
RU2154492C2 (en) Drug for treatment of patient with viral infections, aids and/or aids-associated complex (variants), peptide or its pharmaceutically acceptable salt (variants) and nona- and decapeptides as drugs for treatment of patient with viral infections, aids and/or aids-associated complex
DE69533594T2 (en) PREPARATIONS AND METHOD FOR TRIGGERING CTL IMMUNITY
JP2621970B2 (en) An effective antagonist of hormone releasing luteinizing hormone that releases very little histamine
US7732412B2 (en) Methods of treatment using novel LHRH antagonists having improved solubility properties
EP0593491B1 (en) Luteinizing hormone releasing hormone antagonist peptides
NO176440B (en) Synthetic nonapeptide and decapeptide analogues of LHRH for use in the regulation of fertility and reproductive cycle in humans and livestock
JP2002534480A (en) Improved saponin adjuvant compositions and methods related thereto
GB1590659A (en) Immunological adjuvant constituted by the p-aminophenyl derivative of n-acetylmuramyl-l-alanyl-d-isoglutamine
WO2013133405A1 (en) Pharmaceutical composition containing peptide
KR860000453B1 (en) Process for preparing peptides
JPH0656696A (en) Immunogenicity carrier system
JP2023029958A (en) Novel compounds (immunorhelins)
US20100021487A1 (en) Vaccines and methods for controlling adiposity
KR19990022538A (en) Improved peptides, immunogenic compositions and vaccines or medical preparations for X luteinizing hormone-releasing hormone, methods for immunizing animals, and their use as analogs and vaccines of luteinizing hormone-releasing hormone serial repeat peptides
JP5746970B2 (en) Pharmaceutical composition using a combination of gonadotropin releasing hormone (GNRH) variants as an immunogen
Finstad et al. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy
CN102574904A (en) Motilin-like peptide compound having transmucosal absorbability imparted thereto
WO2010142060A1 (en) Lhrh antagonist with long potency and low histamine releasing effect
US20240033320A1 (en) Immunorhelin compounds for intracellular infections
JP6143270B2 (en) Myostatin inhibitory peptide
JPH08505611A (en) LHRH antagonist having modified aminoacyl residues at the 5th and 6th positions
EP0338437B1 (en) Synthetic vaccins against foot and mouth disease and their preparation process
DE60125959T2 (en) DISTINCTION BETWEEN GNRH-I AND GNRH-II

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09845669

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09845669

Country of ref document: EP

Kind code of ref document: A1